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INTRODUCTION 
 
 
 
1. The Adult Skeletal Muscle Tissue: functions and characteristics 
 
The primary functions of the skeletal musculature are locomotor activity, 
postural behavior and breathing. Moreover, the muscle tissue is a primary site for 
glycogen storage, insulin uptake and amino acid catabolism, playing a crucial 
role in metabolism and heat production, through the contraction of muscle fibers. 
Skeletal muscle is composed predominantly of post-mitotic, multinucleated 
muscle fibers which are formed during development by fusion of mononucleated 
muscle progenitors originating from the somite. Muscle fibers, the basic 
contractile units of skeletal muscle, are individually surrounded by a thin 
connective tissue layer (endomysium) and grouped into bundles within the 
perimysium. The whole skeletal muscle is wrapped by a dense layer of 
connective tissue, called epimysium (Figure 1). Skeletal muscles are highly 
vascularized to provide essential nutrients for muscle functions and innervated to 
ensure muscle fiber contraction. A single motor neuron contacts a mature 
myofiber, which express different MHC isoforms and metabolic enzymes. Each 
muscle fibers is surrounded by the sarcolemma (plasma membrane) and has a 
cytoplasm called sarcoplasm, with numerous mitochondria, sarcoplasmic 
reticulum and myofibrils (Figure 1). Myofibrils, long protein bundles (1µm 
diameter), are composed by the myofilaments of myosin and actin, which 
constitute the sarcomere, the unit of the muscle contraction. The actin filaments 
are associated with other important regulatory proteins, such as troponin 
and tropomyosin, which are necessary for muscle contraction. Skeletal muscle 
cells are excitable and are subject to depolarization by the 
neurotransmitter acetylcholine, released at the neuromuscular junction by motor 
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neurons. The basic mechanism of muscle fibers contraction results from the 
“sliding mechanism” of the myosin-rich thick filaments over the actin-rich thin 
filaments after neuronal activation. Once a cell is sufficiently stimulated, 
the sarcoplasmic reticulum releases ionic calcium (Ca2+), which then interacts 
with the regulatory protein troponin. Calcium-bound troponin undergoes a 
conformational change that leads to the movement of tropomyosin, subsequently 
exposing the myosin-binding sites on actin. This allows for myosin and actin 
ATP-dependent cross-bridge cycling and shortening of the muscle. The 
connective tissue combines the contractile myofibers into a functional unit, in 
which the contraction of myofibers is transformed in movement via 
myotendinous junctions at their ends, where myofibers attach to the skeleton by 
tendons. 
Individual adult skeletal muscles are composed by a mixture of myofibers 
with different physiological properties: slow-contracting/fatigue resistant type, 
fast-contracting/non-fatigue resistant type. The proportion of each fiber type 
within the muscle controls the contractile property of  muscle . Different 
signaling pathways and myoblast populations are involved in the early fiber type 
differentiation, which is established during early development. At the later stages, 
motor neurons and hormones play a fundamental role in determining the fiber 
type, even if individual muscles still retain an intrinsic commitment to form 
particular fiber types [1].  
The terminally differentiated muscle fiber is not a fixed unit but can 
undergo change in fiber type (fast-to-slow or slow-to-fast switch) or fiber size 
(atrophy/hypertrophy). Muscle fibers can also repair local damages caused by 
eccentric contraction (i.e. lengthening) without obvious changes in myofibers 
and surrounding tissues and do not involve inflammatory response. However, 
more severe injuries resulting from traumatic lesions or from indirect causes 
such as neurological dysfunction or innate genetic defects, activate a finely 
orchestrated set of cellular responses, resulting in the regeneration of a well-
innervated and fully vascularized skeletal muscle tissue. 
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Figure 1. Scheme of skeletal muscle and associated structures. Three connective tissue layers 
can be distinguished in skeletal muscle. The epimysium is the deep fascia component that wraps 
the entire muscle and it is contiguous with the tendon (muscle to bone) and endosteum (fascia 
surrounding bone). The perimysium ensheaths individual muscle fibres into fascicules (bundles). 
The endomysium is located between fibres and it ensheaths individual muscle fibres. The muscle 
cell (myofibers) are characterized by the presence of the sarcoplasmic reticulum, the major 
intracellular source of calcium needed for muscle contraction, which connects to the transverse 
(T) tubules, and these surround the sarcomeres. Satellite cells (SCs) are located between the 
basement membrane and the plasmalemma of the myofibre. Image in upper right is a section of 
the tibialis anterior muscle of a mouse that was perfused with India ink to label the vasculature 
and stained with X-gal to reveal SCs in a Myf5nlacZ adult mouse [2]. 
 
Introduction 
 
- 4 - 
 
 
2. The Skeletal Muscle Regeneration 
 
Skeletal Muscle possesses the remarkable capacity to complete a rapid and 
extensive regeneration, even following severe damage. The regenerative ability 
of skeletal muscle relies on Satellite Cells (SCs). SCs are located between the 
sarcolemma and the basal lamina of muscle fibers (Figure 1, 2).  
 
 
Figure 2. Satellite Cells (SCs). Fluorescence microscopic image of a mitotic SCs (metaphase) 
on a mouse muscle fiber. SCs is labeled by the expression of a yellow fluorescent protein and 
DNA is stained in blue [3]. 
 
In response to injury, SCs proliferate and differentiate to either fuse with 
existing myofibes or with other myogenic cells to generate new muscle fibers. 
The program of SCs activation and differentiation recapitulates in some way 
embryonic myogenesis, even if the regulatory mechanisms and the 
microenvironments in the two contexts are different. 
Muscle regeneration consists of two different phases: the degenerative phase 
characterized by a massive inflammatory reaction and the regenerative phase, 
defined by the activation of SCs and the maturation and remodeling of 
regenerated muscle. 
 
Degenerative phase 
The inflammatory reaction. The muscle fiber necrosis represents the first event 
in the regeneration process, leading to a dissolution of the myofiber sarcolemma 
with consequent calcium influx and activation of calcium-dependent proteases, 
such as calpains that can cleave myofibrillar and cytoskeletal proteins [4]. The 
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disruption of muscle fibers integrity is reflected by increased serum levels of 
muscle proteins. For example, creatine kinase, which is usually restricted to the 
myofiber cytosol, is increased in human and animal models after mechanical 
stress and in the course of muscle degenerative diseases [5]. Neutrophils (defined 
by Ly6C+/F4/80-) represent the first myeloid cell population that appear after the 
acute muscle injury, with a significant increase in number within 2 hours after 
muscle damage, peaking in concentration between 6 and 24h and then they 
rapidly decline. After the neutrophil infiltration approximately, 24h post-injury, 
early phagocytic macrophages (CD68+, CD163-) become the major inflammatory 
cell population within the injured site until ~2 days post injury when their 
numbers start to decline. Macrophages secrete pro-inflammatory cytokines such 
as Tumor Necrosis Factor α (TNFα) and interleukin 1β (IL-1β) to 
promote/control/influence phagocytosis of necrotic tissue. Then, non-phagocytic 
macrophages (CD68-/CD163+) increase, reaching their peak at 2 to 4 days after 
injury and their number remains elevated for many days. They secrete anti-
inflammatory cytokines that contribute to switch off the inflammatory response. 
This phase gives way to the regenerative phase of myogenesis. 
 
Regenerative phase 
Activation of SCs and maturation/remodeling of new regenerated muscle. 
Following injury, SCs are activated and undergo rapid proliferation starting ~ 48 
hours after injury. Myogenic cells differentiate and fuse to existing fibers or 
together to generate new fibers.(Figure 3A).Normally, large number of new 
myofibers are formed in few days after muscle damage. Early studies proposed 
that new muscle fibers are generated via budding of myotubes from existing, 
injured fibers. However, it has been supported by several experimental evidences 
that this rapid repair occurs through the activation and differentiation of SCs, 
which represent the major candidate for the source of myogenic cells for muscle 
repair during injury-induced regeneration. Multinucleated myotubes could 
indeed be generated in vitro from single myogenic precursor cells, derived from 
muscle SCs [6-8]. In vivo transplantation-based approaches highlighted the 
regenerative potential of SCs. Donor SCs can be transferred into muscle of 
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injured or diseased mice and they are able to contribute extensively to the 
formation of new muscle fibers, in some cases engrafting the majority of fibers 
in the transplanted muscle. Transplantation into dystrophic mouse muscle of a 
single muscle fiber that contained as few as seven SCs led to an increasing 
number of new SCs that in turn generated more than 100 new muscle fibers and 
could also be activated after injury [9]. In addition, skeletal muscle precursor 
cells derived from SCs, can contribute to up to 94% of myofibers, restoring 
dystrophin expression and significantly improving muscle histology and 
contractile function in dystrophic-deficient mdx mice [10]. More directly, Sacco 
et al (2008) showed that a single muscle stem cell can be transplanted in a host 
injured muscle and it is capable alone of extensive proliferation, contributing to 
muscle fibres regeneration and repopulation of the SC pool [11]. This was first 
demonstration that a SC displayed stem cell character. In summary, SCs 
represent the most important and efficient source for repair of extensive muscle 
injury preserving the regenerative capacity of skeletal muscle throughout life.  
During the regeneration process several factors are involved in the subsequent 
growth of regenerated muscle: involvement of blood vessels and re-
establishment of neuromuscular and myotendinous connections. A 
morphological hallmark of regenerated muscle is the presence of myofibers of 
small caliber with centrally located nuclei (Figure 3B). New generated myofibers 
are generally basophilic and express embryonic/developmental forms of MHC, 
reflecting de novo fiber formation [12]. Once the fusion of myogenic cells is 
completed, newly generated myofibers increase in size and myonuclei migrate at 
the periphery of the fibers. Thus, under normal circumstances a regenerated 
muscle is morphologically and functionally undistinguishable from undamaged 
muscle.  
Nonetheless, during aging or under several pathological conditions, the ability 
of skeletal muscle to fully regenerated is compromised. Several factors can affect 
the intrinsic property of the skeletal muscle tissue to regenerate, leading to the 
generation of abnormal muscle fibers. Indeed, regenerating myotubes, which 
reside in the same basal lamina, may not fuse together leading to the formation 
of cluster of small fibers, or they can give rise to forked fibers, due to the fusion 
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only at one extremity (fiber splitting). After segmental necrosis, SCs can 
proliferate and fuse at the damaged site, giving rise to appearances as “budding”. 
Scar tissue formation can prevent the reconstitution of myofiber integrity leading 
to myotendinous junctions.  
 
 
 
 
Figure 3. Skeletal Muscle regeneration. A. Muscle repair is mediated by myofibers (Mf) 
resident SCs (light blu).After damage activated SCs proliferate as myoblasts (Mb), differentiate 
and migrate in order to fuse each other to repair muscle. B. H&E staining shows uninjured and 
regenerating muscle after 3 and 14 days regeneration. Normally, muscle is characterized by 
peripherally located nuclei (red arrowhead). Three days after injury, muscle shows extensive 
inflammatory infiltrate and some small regenerating fibers with characteristic centrally located 
nuclei. At 14 days, the muscle is fully repaired, but regenerated fibers are still distinguishable by 
their central nuclei [13]. 
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3. Skeletal Muscle Satellite Cells (SCs) 
Identification, distribution and characterization 
Skeletal muscle SCs have long been considered as a population of muscle-
specific adult stem cells that are the major contributor to the postnatal 
maintenance, growth, repair and regeneration of the skeletal muscle tissue [14]. 
This population of adult stem cells was described for the first time by Alexander 
Mauro in 1961. He observed and identified by electron microscopy a population 
of mononucleated cells located in a “satellite” position between the basal lamina 
and the sarcolemma of frog muscle fiber [15]. He supposed that these cells were 
dormant embryonic myoblasts that recapitulate the embryonic muscle 
development after injury. Indeed, during development, the SCs originate from 
paraxial mesoderm-derived cells of the dorsal somites [16]. These cells are 
specified by signals from neighboring cells of the notochord, neural tube and 
dorsal ectoderm through the action of transcription factors such as the paired box 
proteins Pax3 and Pax7 [17-18]. Once committed, somite-derived cells migrate 
to multiple sites of embryonic myogenesis, express the myogenic basic helix-
loop-helix transcription factors (MRFs) Myf-5 and MyoD [19] and differentiate 
into muscle fibers. Pax3 and its paralogue Pax7 have been implicated in the 
specification of cells that will enter the myogenic program. In the absence of 
both Pax3 and Pax7, there is a major deficit in skeletal muscle, with arrest of 
myogenesis occurring during later embryonic and fetal development [20]. Pax3 
is required for the establishment of limb muscles and the migration of embryonic 
precursors from the somites to the limbs [20]. Instead, Pax7 is dispensable for 
prenatal muscle formation but it is required for normal postnatal muscle growth 
[21-22]. Moreover, Pax7 is present in adult SCs, and in its absence muscle 
regeneration is severely affected. SCs were not observed in the mutant, leading 
to the proposal that Pax7 is also essential for the specification of adult muscle 
progenitor cells [21]. Somite-derived myogenic progenitors that do not 
differentiate into myofibers at this time have been suggested to form the adult SC 
pool. Several in vitro and in vivo studies support Pax7 critical role in adult 
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muscle stem cells [22-26]. Genetic lineage tracing approaches shown that the 
majority of all adult quiescent SCs expressed at some point during their 
development the MRFs Pax3, Myf5, MyoD and Pax7 [26-29]. 
The muscle progenitors give rise to specialized muscle fiber associated SCs. 
They are found beneath the basal lamina and adjacent to the plasma membrane 
of mature muscle fibers [15] and first appeared in the limb muscles of mouse 
embryos at E16-18. SCs are most abundant early in life in neonatal mice and SCs 
nuclei comprise approximately 30% of myofibers-associated nuclei. However, 
SCs number declines with age, and only about 5% of myofibers nuclei in the 
muscles of adult mice represent SCs [30]. Adult SCs reside in a quiescent state 
within the basal lamina surrounding individual muscle fibers. This well-defined 
anatomical niche protects SCs from the external environment, even if the SCs are 
capable to respond to external perturbation. In this dormant state, they are 
characterized by a high nuclear-to cytoplasmic ratio, reduced organelle content 
and a smaller nucleus size with increased amount of heterochromatin compared 
to fiber myonuclei [31]. 
SCs can be identified by numerous markers [32]. The most useful marker, 
Pax7 uniformly marks adult SCs. Numerous works have shown how to isolate 
and functionally characterize myogenic subpopulations of myofibers-associated 
cells, using various combinations of markers: α7-integrin+CD34+ [11], Myf5Cre-, 
α7-integrin+ β1integrin+ [33], syndecn3/4+ [34], CXCR4+, β1integrin+ CD45-, 
Mac1-, Sca1- [10]. Nonetheless, all these population of muscle stem cells, that 
maybe represent a subset of a common pool of muscle SCs, express Pax7. This 
transcription factor was first described by Seale et al (2000) as a marker of SCs 
and is essential for their specification and expansion [20-22]. Then, its 
expression is downregulated when SCs commit to muscle differentiation. By 
lineage tracing experiments, Lepper et al. showed that Pax7 expression marks 
adult stem cells in injury-induced myogenesis in vivo [26]. Moreover, Shea et al. 
demonstrated for the first time that Pax7Cre derived cells contribute to 
myofibers differentiation and fully restore the renewed SCs pool back to 
homeostasis during repair [35]. However, it seems that there is a cell intrinsic 
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difference between neonatal progenitors and adult SCs in their Pax7 dependency. 
Pax7 is required for myogenic function within the early postnatal growth period 
but dispensable for repair. Indeed, when Pax7 is inactivated in adult mice, 
mutant SCs are not compromised in muscle regeneration, they can proliferate 
and reoccupy the sublaminal satellite niche, supporting further regenerative 
process. [26]. These recent findings highlight the differences between adult and 
embryonic/post natal SCs. However, the heterogeneity in gene expression and 
myogenic potential in the population of SCs, and the findings that many other 
stem cells can contribute to muscle regeneration arise the question if Pax7+ SCs 
represent the major cell type involved in muscle repair. Bone marrow derived 
progenitors [36], skeletal muscle side populations [37], mesangioblasts [38], 
pericytes [39-40], CD133(Prom1)+ progenitors [41], PW1(Peg3)+ interstitial 
cells [42] have been showed to incorporate into newly formed myofibers. In 
addition, fibroblastic/adipogenic mesenchymal progenitors (FAPs) interact with 
SCs to regulate muscle homeostasis [43]. However, how much these cells can 
contribute to the normal physiological muscle repair remain still unclear. Recent 
significative works describe with different genetic ablation approaches that Pax7 
expressing SCs are indispensable and required for adult skeletal muscle 
regeneration. Sambasivan et al (2011), used a knock in Pax7DTR mouse model, 
which express a diphtheria toxin DT receptor (DTR) under the control of Pax7 
gene promoter. The intramuscular administration of DT, potent inhibitor of 
protein translation, ablate all Pax7DTR+ cells, leading to a marked loss of muscle 
tissue and failure to regenerate skeletal muscle. In addition, skeletal muscle 
become infiltrated by inflammatory cells and adipocytes [44]. In the other study 
by Lepper et al (2011), they used Pax7CreER in combination with R26ReGFPDTA. 
In this model with the injection of tamoxifen all Pax7+ cells will express the 
diphtheria toxin fragment A (DTA) which mediates cell autonomous killing. 
They found that the elimination of Pax7+ cells completely blocks the 
regeneration after TA injury and after transplantation of EDL muscle into nude 
mice [45]. In the last work, Murphy et al (2011) used Pax7CreERT2 and Tcf4CreERT2 
crossed with R26RDTA mice to genetically ablate SCs and fibroblasts. The 
ablation of SCs resulted in a complete loss of regenerated muscle, as well as 
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misregulation of fibroblasts and dramatic increase in connective tissue. Instead, 
the fibroblasts ablation causes premature differentiation of SCs, depletion of the 
early pool of SCs and smaller regenerated fibers [46]. Therefore, all these results 
showed that SCs are required for skeletal muscle regeneration and the loss of 
SCs is not compensated by other stem cell types. Muscle regeneration, indeed, 
was rescued after transplantation of only adult Pax7+ cells [44]. Other cell types 
which possess regenerative potential are strictly dependant on the presence of 
SCs. 
 
 
Figure 4. Pax7SCs are capable to self renewal and contribute to muscle regeneration. 
Pax7+/XGal+ SCs in muscle of Pax7-CreERtm;R26R-lacZ mouse reporter. Transverse sections 
show Pax7+/X-gal+ mononucleated cells in the SCs position of uninjured (0 days) and 
regenerated muscle fibers (50 days) (black arrows) [35]. 
 
 
 
 
Cellular and molecular control of SCs-lineage progression 
Several works, with the use of inducible lineage tracing approaches, showed 
that after injury, quiescent adult Pax7+ cells become activated myoblast 
progenitors and they enter the cell cycle. Only a subpopulation of these cells 
come back to quiescence to replenish the SCs compartment, while others 
contribute to the new muscle fiber formation [26, 35]. 
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The progression of activated SCs toward myogenic differentiation is 
controlled by the Myogenic Regulatory Factors (MRFs). They belong to a family 
of transcription factors that share a homologous basic helix-loop-helix (bHLH) 
domain responsible for DNA binding and dimerization with members of the E 
protein family. MRF-E protein dimers bind the E-box elements (CANNTG) 
found in the promoters of key muscle-specific gene [47]. Activated Pax7+SCs 
upregulate MyoD expression and proliferate to form myoblasts. Some of the 
Pax7+/MyoD+ cells return to quiescence though the downregulation of MyoD, a 
critical step of the reversion to quiescence. Indeed, it has been shown that Pax7, 
which is transcriptionally active during the quiescent state, is sufficient to 
promote the return to quiescence through repression of MyoD [24, 48-49]. The 
majority of the proliferating myoblasts progress toward the differentiation 
program characterized by the downregulation of Pax7 and the Myogenin 
upregulation. Finally, differentiated mononuclear myogenin+/MyHC+ (Myosin 
Heavy Chain) myocytes fuse together to form multinucleated myotubes or 
nascent myofibers (Figure 5). 
 
 
Figure 5. MRFs and myogenic lineage progression. Quiescent Pax7+SCs are activated and 
proliferate as Transient Amplifying Cells (TAC) characterized by the coexpression of Pax7 and 
MyoD. The majority of TAC pool follow the myogenic lineage progression becoming fusion 
competent cells characterized by the downregulation of Pax7. Finally, they are able to fuse and 
form differentiated multinucleated myotubes overexpressing Myogenin (MyoG). Some of the 
activated TA Pax7+/Myod+ cells are able to self renewal and reestablish the pool of quiescent 
SCs. (Courtesy of Andrew S. Brack). 
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The host fiber, as well the basal lamina, represent important factors for the 
SCs niche. For instance, it has been shown that mechanical, electrical and 
chemical signals originating from the host fiber can modulate the activity of SCs 
[14]. Furthermore, signals coming from the microvasculature and interstitial cells, 
such as macrophages, fibroblasts and muscle-resident stem cells also constitute 
an important component of the SCs niche (Figure 6). However, whether other 
resident cell population can control the SCs quiescence remains unclear. A 
number of different signaling pathways have been associated to the regulation of 
muscle SCs function such as Ang1/Tie-2, Notch, Wnt and Sonic Hedgehog 
pathway. Recently, HGF and Ang1 have been implicated as quiescence-inducing, 
ligand derived-growth factors [50-51]. Notch signaling controls quiescence and 
promotes stem cell fate decisions. Indeed, Notch3 is highly expressed in dormant 
Pax7+ SCs and proliferating SCs have high expression of Notch ligand Delta [52-
53]. In addition, Notch signaling seems to inhibit myogenic differentiation 
through the upregulation of Numb, an inhibitor of Notch signaling. Then, a 
temporal balance between Notch and Wnt signaling controls the coordination 
from myoblasts to differentiated cells [54]. Many other factors have been 
identified to act by regulating SCs quiescence and activation, such as Fibroblast 
Growth Factors (FGF), Insulin Growth Factors (IGF), hepatocyte Growth 
Factors (HGF), Transforming Growth Factors β (TGFβ) and Interleukin 6 (IL6) 
[55]. In addition, RTK (Receptor Tyrosine Kinase) are key mediator of grow 
factor signaling response, (i.e. FGF). Sprouty (Spry) represents a downstream 
target and negative regulator of RTK signaling. Recently, Shea et al (2010) 
showed that Spry1 is robustly expressed in quiescent SCs in uninjured adult 
muscle. Then, Spry1 expression is downregulated in activated SC after injury, 
and re-expressed as soon SCs go back to quiescence. They also showed that 
disruption of Spry1 using either inducible Pax7CreERtm allele or a germline 
knockin approach reduces the pool of SCs that return to quiescence. Therefore, 
Sprouty1 plays a pivotal role in sensing growth factors within the environment 
and regulating SCs quiescence during muscle growth and repair [35, 56].  
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Figure 5. The SCs niche and regulatory factors. Schematic representation of the different 
enviromentalcues influencing SCs niche. FGF fibroblast growth factor; HGF hepatocyte 
growth factor; IGF, insulin-like growth factor; MGF mechano-growth factor; NO, nitric 
oxide; TGF, transforming growth factors [3]. 
 
 
 
4. Changes in muscle SCs during Muscle Disease and Aging 
Several muscle pathological conditions, such as congenital myopathy, 
denervation, muscle atrophy, which are characterized by progressive loss of 
muscle mass and strength, may exhibit a decrease in the number and proliferative 
potential of SCs. The underlying mechanisms responsible for these changes of 
SCs pool and activity are still not completely understood. During chronic 
degenerative conditions, skeletal muscle undergoes through multiple bouts of 
regeneration and degeneration. In this context the repeated cycle of activation 
and proliferation of SCs may lead to telomere shortening or accumulation of 
mutations in specific SCs genes, resulting . SCs exhaustion may also be related 
to frequent exposure to inflammatory conditions, oxidative stress. Moreover, non 
myogenic cells in the  diseased muscle (i.e.fibroblasts) can affect muscle 
regeneration [57]. During aging there is a gradual decline in the regenerative 
potential of most tissue, due to a combination of age-dependent changes in the 
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environments and in the tissue specific stem cell. In aging skeletal muscle, 
damaged muscle fibers are less frequently regenerated by new fibers, leading to 
age-dependent loss of muscle mass and decline in strength, commonly referred 
as sarcopenia. Age-related deficits in muscle regeneration have been linked to 
functional decline in muscle SCs and their ability to repair skeletal muscle after 
injury [58-59]. Extrinsic change in aging muscle stem cells (i.e. Notch, Wnt 
signaling pathway) and intrinsic alteration can affect the regenerative ability of 
SCs. Indeed, the lack of SCs entering the cell cycle, and the exposure to an 
oxidative and inflammatory stress, makes SCs more susceptible to accumulation 
of cellular and genotoxic insults. In the aging context stem cells also can go 
though the senescence process upregulating the tumor suppressor gene and cell 
cycle inhibitor p16Ink4a. P16Ink4a expression has been described in several 
tissue from aging mice and human, as well it has been correlated with replicative 
decline in the HSC and NSC compartments [60]. 
 
4.1 Amyotrophic Lateral Sclerosis (ALS) and the possible Skeletal Muscle 
involvement  
Amyotrophic Lateral Sclerosis (ALS) represents the most common form of 
the adult-onset motor neuron diseases (MND). ALS, first described by the 
French neurobiologist and physician Jean-Martin Charcot, is a fatal 
neurodegenerative disorder that mainly affects pyramidal neurons in the motor 
cortex and lower motor neurons (MNs) that originate in the brainstem and spinal 
cord. The name of the disease reflects the different tissue compartments that are 
severely affected. In particular, amyotrophic refers to the atrophy of the skeletal 
muscle fibers and loss of muscle mass; lateral refers to nerve tracks that run 
down both sides of the spinal cord; sclerosis reflects the scar tissue that remains 
after MNs degeneration 
The most typical feature of this progressive lethal disease is the selective and 
premature degeneration and death of cortical and spinal MNs leading to the 
clinical characteristics of muscle weakness, fasciculations, muscle atrophy, 
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speech and swallowing disabilities, progressive paralysis, and death caused by 
respiratory failure, which usually occurs within 2-5 years of disease onset 
depending on the severity and the stage of disease when diagnosed. 
Although the majority of incidences have no apparent hereditary contribution 
and are, hence termed sporadic, the remainder (~10%) are of genetic origin, 
generally transmitted with an autosomal dominant inheritance [61]. During these 
years several genes have been studied and linked to familial ALS (fALS), 
including angiogenin, vapb, dynactin, tdp43, fus/tls. However, how the mutation 
of these genes trigger ALS is still unknown [62-64]. A landmark discovery 
reported in 1993 initiated the molecular era of ALS research with identification 
of mutations in the gene encoding the superoxide dismutase 1 (SOD1) as 
causative in 20% of the inherited cases [65]. SOD1 normally functions as an 
enzyme involved in oxidative stress resistance, converting highly reactive 
superoxide to either hydrogen peroxide or oxygen. There is convincing evidence 
that mutant SOD1 (mSOD1) kills MNs because of a neurotoxic property (gain of 
function hypothesis) rather than a deficiency in dismutase activity (loss of 
function hypothesis) [64]. However, the pathophysiological mechanisms of ALS 
are still elusive. A number of mechanisms have been proposed by which mSOD1 
leads to MNs cell death, including the following: misfolding of the mutant 
protein, interference with axonal transport or cytoplasmic trafficking, altered 
oxidative activity of the mutant enzyme, a defect in the EAAT2 glutamate 
transporter leading to excitotoxicity [66]. Nonetheless, recent works highlighted 
the fact that MNs are not the only cell type involved in ALS pathogenesis, 
challenging these “neurocentric” view. Other cell types, such as glial cells and 
skeletal myofibers, seems to participate in the triggering of MNs degeneration 
[63, 67-68]. Indeed, the first event in the disease process in mSOD1 mice is the 
interruption of the nerve connection at the neuromuscular junction (NMJ), 
followed by axonal degeneration and death of MNs cell bodies [69]. 
The controversial discussion still continues as to what extent muscle 
denervation in ALS models is of neuronal origin. Neuron-restricted expression of 
mSOD1 does not recapitulate the hallmarks of the disease [70-71], possibly due 
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to low mSOD1 expression levels [72]. Involvement of skeletal muscle in ALS 
pathophysiology was first understood from early muscle hypermetabolism in 
mSOD1 mice and human patients [73-74]. Moreover, it has been found that the 
neurite outgrowth inhibitor Nogo-A is strongly expressed in ALS skeletal 
muscles [75]. Recent studies provide evidence that skeletal muscle-specific 
mSOD1 overexpression is sufficient to induce muscle atrophy and oxidative 
damage and trigger key features of ALS in spinal cord such as astocytosis and 
inflammation, as well as MNs degeneration [68, 76]. Williams AH et al (2009) 
reported that miR-206, a microRNA specifically expressed in the skeletal 
muscles, delays ALS progression and promotes regeneration of neuromuscular 
synapses in mouse models. Indeed, loss of miR-206 accelerates disease 
progression and atrophy of skeletal muscle, leading to kyphosis, paralysis and 
death [77]. 
All this evidence reinforce the hypothesis that skeletal muscle appear to be 
involved in ALS pathogenesis in conjunction with other cell types. It is well 
known that the connection between muscle and nerve is crucial for both cell 
types in order to survive and function throughout the life (Figure 1). Moreover, 
skeletal muscle is also a source of signals that influence neuron survival, axonal 
growth and maintenance of synaptic connections [78]. Indeed, the development 
in absence of skeletal muscle results in the sequential ablation of MNs from the 
spinal cord to the brain [79]. Thus, skeletal muscle plays a crucial role in 
providing guidance and cues to the developing MNs, and sustain a trophic 
support for the maintenance of MNs and the axon function. On the other side, the 
first stages of muscle regeneration after injury and the activation, proliferation, 
differentiation and fusion of SCs, can take place in the absence of nerves. 
However, their presence is fundamental for growth and maturation of newly 
formed myofibers, which in absence of neural activity remain atrophic. The role 
of nerve activity in muscle regeneration is demonstrated in rat soleus muscle 
after muscle injury induced by bupivacaine injection. Bupivacaine causes the 
necrosis of all soleus muscle fibers, leaving SCs, nerve terminals, as well as 
blood vessels, intact. After 3 days of regeneration both the innervated and the 
denervated muscles are composed of thin myotubes expressing embryonic 
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MyHC. The innervations process starts approximately at day 3 after injury [80-
81]. Three days after injury, denervated regenerating myofibers do not display 
further growth, compared to the innervated muscles.  
Although the denervation of NMJ in ALS is clear, the potential alteration in 
myogenic regulation remain unexplored. Indeed, muscle autonomous mSOD1 
toxicity may limit the capacity of mutant muscle to regenerate, modifying the 
activity of SCs and the MRF molecular regulation. It seems, indeed, that SCs 
isolated from ALS patients are affected in their capacity to proliferate and 
differentiate. Pradat et al, (2011) showed that the dividing myoblasts in vitro 
exhibited abnormal morphological features reminiscent of senescent cells. 
Moreover, during differentiation, these cells form long thin myotubes with 
weaker MHC isoform expression [82]. Nonetheless, more studies are required in 
order to understand whether SCs abnormalities or defects in the program of 
muscle differentiation and maturation in ALS may be a part of the non-cell-
autonomous process. 
 
4.2 Role of P16Ink4a in cell cycle and tissue regeneration 
Cell Cycle progression through positive and negative regulators 
During the early process of skeletal muscle differentiation, MRFs are 
involved not only in the control and regulation of muscle specific genes, but also 
in modulating the transition from quiescent SCs, to Transient Amplifier Cells 
(TAC) towards differentiated myotubes. This transition requires cell cycle 
withdrawal during the G1 phase. Along cell cycle progression, and in particular 
in G1 phase, checkpoints are encountered. Depending on the ability to pass these 
points, the cell will determine its fate. Indeed, cells can enter in a reversible 
quiescent state (G0), or differentiate in a more specialized non-proliferating cells. 
Cells can become senescent, metabolically active, but in a permanently retired 
state or lastly, they can go through apoptotic mechanisms and die. Therefore, it is 
clear that there is an extremely fine crosstalk and balance between MRFs and 
cell cycle regulators during myogenesis [83-84].  
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  The G1 cell cycle phase is controlled at the molecular level by several 
positive and negative regulators. In particular, among the positive regulators 
there are cyclins and cyclin-dependent kinases (CDKs) (Figure 6). The CDKs 
belong to the class of protein serine-threonine kinases and depend on the binding 
of a cyclin in order to become activated by a CDK-activating kinase. Then, the 
activated Cyclin-CDK complexes are able to phosphorylate downstream targets, 
such as cell cycle repressors. Cyclin D is one of the major regulators of G1 phase 
progression. After mitogen stimulation, Cyclin D is upregulated in the early 
phase of G1. The association of Cyclin D with CDK4 or CDK6 , lead to the 
phosphorylation of the retinoblastoma protein, Rb. Rb functions as a tumor 
suppressor gene. Indeed, in hypophosphorylate state it is active and repress cell 
cycle progression by inhibiting E2F transcription factors. Therefore, the 
CyclinD/CDK4/6-mediated phosphorilation of Rb causes the release of Rb from 
E2F, which is now available for the transcription of late G1/S phase genes. 
 
Figure 6. Cell cycle progression and G1 phase regulation. Diagram depicting the four phase of 
cell cycle and the cyclin/CDK complexes that are crucial for progression. Regulation of G1 phase 
by CDK inhibitors, cyclin/CDK complexes [85]. 
 
Cdk inhibitors (CKIs) and pocket proteins of RB family, such as p107 and 
p130 are negative regulators of cell cycle progression. The CKI cell cycle 
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inhibitors are divided in two families based upon their structure and cdk targets. 
The first group, known as the INK4 proteins bind specifically to inhibit the 
catalytic subunit of CDK4 and CDK6 and include p15, p16, p18 and p19. The 
second group, the Cip/Kip family, binds to cyclin D-, A- and E-dependant 
kinases via both cyclin and catalytic subunits and include p21, p27 and p57 [86] 
(Figure 6). 
The locus INK4a/ARF/INK4b (also known as CDKN2a and CDKN2b) 
encodes three genes within 35kb: ARF (also known as p19ARF and p14ARF), 
p15INK4b and p16INK4a. Whereas p15INK4b has its own open reading frame that is 
physically distinct, p16INK4a and ARF have different first exons that are spliced to 
a common second and third exon. Even if p16INK4a and ARF share both exon 2 
and exon 3, the proteins are encoded in alternative reading frames. Therefore 
p16INK4a and ARF are not isoforms and do not share any amino acid homology 
(Figure 7). The INK4 class of cell cycle inhibitors p15INK4b, p16INK4a, p18INK4c 
and p19INK4d (different from p19ARF) are homologous inhibitors of CDK4/6. 
The binding of the INK4 proteins to CDK4/6 induces an allosteric change that 
abrogates the binding of this kinase to Cyclin D, inhibiting the Rb 
phosphorilation. Both p15INK4b and p16INK4a are able to keep Rb-family proteins 
in a hypophosphorylate state, promoting the binding with E2F and the block of 
cell cycle progression at G1 [87-88] (Figure 7). During myogenic progression, 
pRb is maintained in inactive hyperphosphorylate state in cycling TAC and it 
becomes hypophosphorylate and active during myogenic differentiation, 
inhibiting E2F and leading to withdrawal from cell cycle. It has been shown that 
lack of pRb causes severe deficiency of skeletal muscle in newborn pups of Rb1 
knockout mice and when pRb is absent myoblasts show defect in terminal 
differentiation [89]. Recent work showed that loss of Rb1 specifically in SCs 
causes an increase in activated SCs but delay in terminal differentiation. 
Moreover, they observed smaller muscles of postnatal mice and delayed muscle 
regeneration after injury [90]. 
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Figure 7. The INK4a/ARF/INK4b Locus The INK4a/ARF/INK4b locus encodes three genes 
within 35 kilobases: ARF, p15INK4b, and p16INK4a. Members of the INK4 family of cyclin 
dependent kinase inhibitors bind to and inactivate CDK4/6. ARF inhibits MDM2, resulting in 
p53 stabilization. RDINK/ARF indicates a newly discovered origin of replication 5 to p15INK4b 
that participates in the transcriptional silencing of the INK4a/ARF/INK4b locus [87]. 
 
 
p16INK4a-pRB pathway, senescence and aging 
Tissue repair and regeneration are essential for longevity and often depend on the 
proliferation of stem or progenitor cells. In skeletal muscle, as other mammalian 
tissue, the regenerative capacity of resident stem cells declines with age. The 
stem cell population can ensures tissue repair and regeneration, but their 
hyperproliferative property can also drive cancer. Therefore, tumor suppressor 
mechanisms are fundamental in order to prevent malignant cell transformation 
by the activation of process such as apoptosis or senescence. p16INK4a cell cycle 
inhibitor is considered also an important tumor suppressor functioning as a 
mediator of cellular senescence. Cellular senescence is an important mechanism 
to prevent the malignant progression of tumor cells. Senescent cells accumulate 
in various tissue and organs during aging and have been hypothesized to affect 
tissue structure and function [91]. Indeed, p16INK4a expression has been 
associated with cancer and aging in mammalian systems and its expression has 
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been shown to markedly increases with age in the majority of all mammalian 
tissues [92]. Recently, Baker et al (2011) designed a novel mouse model with 
INK-ATTAC transgene for inducible deletion of p16Ink4a-positive senescent cells. 
Basing on this approach they demonstrated that in the BubR1 mouse background, 
the removal of p16INK4a – positive senescent cells upon drug treatment. delayed 
onset of these aging related phenotypes, such as. sarcopenia in skeletal muscle 
[93]. However, these results relies on BubR1 hypomorphic mice model, in which 
the physiological aging process is accelerated. Indeed, BubR1 encodes a key 
member of the mitotic checkpoint, ensuring accurate chromosome segregation 
during mitosis. BubR1 hypomorphic mice shows markedly shortened lifespan 
and prematurely exhibit a variety of age related phenotypes. Other important 
studies have demonstrated that increased p16INK4a expression appears to play a 
role in the age-associated functional decline of the replicative potential of certain 
stem cell compartments, such as HSCs [94], pancreatic β-cells [95-96] and 
Neural Stem Cells (NSCs) [97]. Accordingly, p16INK4a deletion attenuates the 
age-related decline in the repupolation potential of stem cells in these 
compartments [94, 97-98] and partially restores several age-related phenotypes 
in skeletal muscle and fat tissues in a premature aging mouse model (BubR1 
insufficient) [99]. All these data suggest an uncover role for p16INK4a tumor 
suppressor in promoting ageing. However, it remain still not clear how p16INK4a 
drive stem/progenitor cell aging. It may  promotes aging by inducing irreversible 
senescence arrest, or by a reversible quiescent state. Moreover, a caveat of these 
results is that they relied on germline inactivation or overexpression of p16INK4a. 
Therefore, some of age-promoting effects of p16INK4a expression observed in 
these systems may result from developmental compensation or non cell 
autonomous effects.  
 
The regulation of INK4a/ARF/INK4b expression 
p16INK4a activation has been shown to be regulated both at transcriptional 
and post-transcriptional levels. MAPK signaling via ERK and p38MAPK has 
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been suggested to induce p16INK4a expression in response to oncogenic activation 
or stress stimuli. Expression of p16INK4a  can be either transcriptionally activated 
(e.g. Ets family) or inhibited (e.g. Id proteins) by a number of pathways. 
Recently, some studies have suggested also a post-transcriptional regulation of 
p16INK4a through interaction with microRNAs [100]. Additionally, a few 
repressors of INK4a/ARF/INK4b expression have been identified. In particular, 
the PcG (Polycomb Group) proteins, such as BMI1 and EZH2, have been shown 
to epigenetically silence p16INK4a expression. PcG genes are epigenetic chromatin 
modifiers involved in heritable gene repression and maintenance of stem cell 
self-renewal and proliferation. For example, Ezh2, which belongs to the 
Polycomb Repressive Complex 2 (PRC2) is developmentally regulated in 
skeletal muscle and prevents myogenic gene transcription and differentiation 
[101]. Moreover, Juan AH et al (2011), showed that conditional ablation of Ezh2 
in SCs cause a reduction of the pool of Pax7+ cells and muscle mass leading to 
muscle regeneration defects [102]. Therefore, EZH2 controls self-renewal and 
proliferation of SCs, through the maintenance of an appropriate transcriptional 
program. Bmi1 is another PcG that belongs to the PRC1 complex. Bmi1 has 
been shown to play a crucial role in regulating cell cycle entry as well as 
maintaining self-renewal capacity of various adult stem cells. In particular, Bmi1 
deficient mice displays accelerated reduction of HSC [103] and reduced self-
renewal of NSC [104]. Of note, the defects in HSC and NCS observed in 
absence of Bmi1 are partially restored by deletion of Ink4a/Arf. Indeed, the 
action of Bmi1 is in part, mediated through transcriptional repression of 
Ink4a/Arf locus, essential for G1/S cell cycle progression. By repressing CDK 
inhibitors of INK4 family, Bmi1 and the other PcG proteins enable the activation 
of CyclinD/CDK4/6 complex and consequently progression through the G1 
phase of the cell cycle [105]. Bmi1 deficiency has been shown to not have any 
effect on the differentiation of skeletal muscle during embryonic and fetal stage 
[106]. However, it seems that Bmi1 is required for SC maintenance and 
regeneration postnatally. Indeed, SCs from Bmi1 knockout mice show reduced 
proliferative capacity and failure to re-enter cell cycle when exposed to high 
serum conditions [107]. 
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Figure 8. Regulation of p16INK4a and its role in ageing. Activation of p16INK4a can be 
achieved through a variety of mechanisms, including epigenetic, transcriptional, and 
posttranscriptional regulation. Once activated, p16INK4a inhibits the proliferative kinases 
CDK4/6, leading to immune ageing through induction of hypo-proliferation, and perhaps cellular 
senescence [108]. 
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AIMS OF THE PROJECTS 
 
 
 
PROJECT 1 
Isolation and characterization of Satellite Cells (SCs) from patients affected by 
Amyotrophic Lateral Sclerosis (ALS) 
ALS is an adult onset neurodegenerative disease defined as a progressive 
muscular paralysis reflecting degeneration of MNs in the primary motor cortex, 
brainstem and spinal cord [66]. Recently, it has been shown skeletal muscle 
tissue seems to play a role in ALS pathogenesis in conjunction with other cell 
types Dobrowolny [68]. The connection between skeletal muscle and motor 
neurons (MN) is crucial for both cell types in order to function throughout the 
life. Skeletal muscle possess the remarkable ability to regenerate after damage. 
This property relies on the presence of Satellite Cells (SCs), a population of adult 
muscle stem cells. However, the muscle regenerative capacity declines with 
aging and in several neuro-muscular pathological conditions. Nowadays, it is 
still unrevealed if loss of skeletal muscle strength and function in ALS can be 
due also to potential alteration in the activity of SCs and their myogenic. In this 
work, we isolated and characterized SCs from patients affected by ALS. A 
morphological and molecular study was conducted in order to understand and 
define possible alteration in the regenerative property of SCs in a neuromuscular 
disease such as ALS.  
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PROJECT 2:  
The role of P16Ink4a in skeletal muscle regeneration 
The cell cycle regulator P16Ink4a has been studied as an important tumor 
suppressor functioning as mediator of cellular senescence to prevent malignant 
progression of tumor cells [109]. Its expression has been shown to increase with 
age in several mammalian tissue [92]. Recently, P16Ink4a has been involved in the 
reduction of regenerative capacity of different stem cell compartment during 
aging. Aged mice lacking P16Ink4a display improved regenerative capacity [94, 
97-98]. However, the role of P16Ink4a in adult myogenesis has never been 
investigated. In this study we will use two P16Ink4a knock out mouse models, a 
germline mutant and a conditional inducible Pax7CreERtm;P16Ink4a flox/flox, to 
delete P16ink4A specifically in Pax7+ SCs and their downstream progeny in order 
to investigate P16Ink4a function during repair of adult and aged muscle. 
Understanding the role of P16Ink4A in adult SCs will lead new insight into the 
skeletal muscle stem cell biology. Moreover, enhancing the regenerative capacity 
of SCs, new therapeutic strategies can be developed for the treatment of muscle 
disease and aged-associated sarcopenia. 
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RESULTS 
 
 
ALS myoblasts show a greater ability to proliferate but fail to properly 
differentiate  
Skeletal muscle cells were isolated from muscle biopsies (vastus lateralis) of 
7 patients affected by ALS (Age: mean 63,7 ± 9,6 years). However, we were able 
to obtain and expand skeletal pure muscle cell cultures only from 3 biopsies, 
independently from the disease status of patients. Indeed, we know from our 
previous works [110] that the quantity of muscle biopsied is critical to obtain a 
successful culture of pure skeletal myoblasts, while reducing contamination of 
other cells, such as fibroblasts. Skeletal muscle cells are characterized by the 
expression of a specific muscle marker. Therefore, the purity of our cultures, 
based on Desmin marker, was 60% (Figure 1A). Five days after isolation, all cell 
cultures contained rare undifferentiated mononucleated cells with rounded 
morphology. Then they acquired a typical elongated and spindly shape after 7 
days in growing conditions (Figure 1B). At 15 days of culture, ALS myoblasts 
needed to be expanded and passed every 4 days at a ratio of 1 to 2, which 
corresponds to their doubling time. Human ALS myoblasts reduced their 
capacity to proliferate in vitro after 5 passages acquiring the typical flatted 
morphology of senescent cells, similar to healthy age-matched control (Ctrl) 
myoblasts.  
The maintenance of skeletal muscle mass during life depends principally on 
the capacity of SCs to be activated and initiate the myogenic program, in order to 
differentiate and repair muscle damage [14]. Therefore, we first analyzed the 
proliferative ability of ALS myoblast cultures. The growth curve showed a 
significative proliferative advantage of ALS myoblasts after 8 and 12 days of 
culture (P<0,05; P<0.0001) (Figure 2A) compared to Ctrl. In addition, the 
analysis of the Ki67, a cellular marker for proliferation, confirmed that ALS 
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myoblasts are characterized by increased proliferation activity after 4, 8 and 12 
days of culture (Figure 2B, C) compared to Ctrl, as shown from the 
quantification of Ki67+ cells (P<0.0001) (Figure 2B). Our results demonstrated 
that myoblasts isolated from ALS patients rapidly proliferate in vitro. Next, we 
asked if ALS myoblasts were also able to progress through the myogenic 
program and differentiate in vitro, forming multinucleated myotubes. In order to 
differentiate, ALS and Ctrl myoblasts were cultured in low serum media (DM), 
for 7 days and stained for Myosin Heavy Chain (MHC), marker of differentiated 
myotubes. When ALS myoblasts were switched to low-mitogen media, they 
began to elongate and form thin myotubes with few myonuclei (Fig. 2D). After 7 
days in DM, fusion index, calculated as the ratio of the number of myonuclei 
fused into myotubes on the total number of nuclei and expressed in percentage, 
was significantly lower in ALS compared to Ctrl myoblasts (P<0.001) (Figure 
2D). 
Thereby, ALS myoblasts show a high capacity to proliferate in vitro. 
Nonetheless, their differentiative potential seems to be compromised. Indeed, 
they do not progress properly though the myogenic program, giving rise to 
defective myotubes formation. 
 
 
Proliferating ALS myoblasts show ultrastructural feature of high 
undifferentiated cell and cellular abnormalities during differentiation 
Transmission Electron Microscopy (TEM) analysis was carried out to 
evaluate the ultrastructural features of ALS myoblasts in vitro during 
proliferating and differentiating conditions. ALS myoblasts cultured in 
proliferating media showed a very immature and undifferentiated morphology 
compared to Ctrl myoblasts. ALS myoblasts were characterized by a tangled 
mass of rudimentary myofibrils and only few SR (Sarcoplasmic Reticulum) 
(Figure 3B, D) compared to Ctrl (Figure 3A, C). In addition, no mitochondrial 
ultrastructural abnormalities were detected (Figure 3D). Upon differentiation 
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ALS muscle cells revealed the presence of two different cell populations. Indeed, 
ALS myogenic cells showed differentiative elements, such as a large number of 
organized myofibrils with a prominent electron dense Z-line and SR with a 
parallel alignment (Figure 4B, D) as the Ctrl differentiated muscle cells (Figure 
4A, C). Among ALS cells, we also observed some differentiated muscle cell 
with degenerative features. In particular, these cells were characterized by the 
presence of pyknotic nuclei and areas containing few degenerating vacuoles and 
no myofibrils (Figure 4E, F). 
Our experimental analysis suggested that the partial deficiency of ALS 
myoblasts to differentiate may be due in part to some degenerative mechanisms, 
such as necrotic or apoptotic process. 
 
 
Changes in MRFs expression reflect ALS myoblasts high proliferation and 
defective differentiation potential 
Skeletal muscle SCs are regulated by MRFs, which are indispensable for 
progression through the myogenic program [14]. In order to investigate whether 
change in MRFs expression are involved in defective myogenesis of ALS 
myoblasts, we analyzed transcript and protein levels of Pax7, MyoD, Myf4 
(Myogenin), MHC by real time qRT-PCR and Western Blot. Our results 
revealed an increased expression of MyoD transcript and protein and reduced 
transcript level of Pax7 during proliferation in ALS myoblasts compared to Ctrl, 
suggesting that proliferating ALS myoblasts are in a more committed phase 
(Figure 5A, B). Upon differention, MyoD expression was reduced and Myf4 
remains at low expression level in ALS myoblasts (Figure 5A, B). Of note, low 
transcript levels of MHC were observed in ALS myoblasts compared to the Ctrl 
(Figure 5A), confirming the low expression of MHC protein in the smaller ALS 
myotubes (Figure 2D). Therefore, ALS myoblasts show alteration in the 
myogenic regulation which reflects their inability to properly differentiate. 
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FIGURES 
 
Figure 1. Primary ALS myoblasts cell culture.  
A. The purity of primary ALS and healthy aged matched control (Ctrl) myoblast 
cell cultures was quantified based on Desmin expression. Myoblasts were stained 
for Desmin (green) and Dapi (blue). Magnification: 20x. 
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B. Bright field images of freshly isolated ALS myoblasts after 5, 7 and 15 days 
in culture. Magnification: 20x, 10x. 
Data presented as mean and SD. 
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Figure 2. ALS myoblasts show a greater ability to proliferate but fail to 
properly differentiate 
A. Growth curve of primary ALS and Ctrl myoblast cultures. The total number 
of cell after 4, 8 and 12 days in culture was plotted relative to the initial cell 
number at 0 day (n=3). 
B. Quantification of Ki67+ proliferating ALS and Ctrl myoblasts after 4, 8 and 
12 days in culture (n=3). 
C. Representative immunohistochemistry staining for Ki67 proliferation marker 
in ALS and Ctrl primary myoblast cultures. Scale bars represents 50µm. 
D. Primary myoblasts from ALS and Ctrl were switched to differentiating media 
(DM) for 7 days and stained for MHC. Index of differentiation was calculated. 
Data presented as mean and SD (p<0.05) 
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Figure 3 Proliferating ALS myoblasts show ultrastructural feature of high 
undifferentiated cells 
TEM analysis was performed in proliferating Ctrl (A, C) and ALS (B, D) 
primary myoblasts. Magnification: A, B x28.000, C, D x36.000 
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Figure 4. ALS myoblasts show cellular abnormalities during differentiation 
TEM analysis was performed in differenting Ctrl (A, C) and ALS (B, D, E, F) 
primary myoblasts. Magnification: A x5.400, B, E, F x3000, C, x9.100, D 
x10.000. 
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Figure 5. ALS myoblasts show changes in MRFs expression 
A. MyoD, Myf4, Pax7 and MHC transcript level were assessed by real-time 
qRT-PCR from ALS and Ctrl primary myoblasts in proliferating and 
differentiating culture conditions (n=3). 
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B. Western Blot analysis of MyoD and Myf4 in proliferating and differentiating 
ALS and Ctrl myoblasts. RD18 cells (rhabdomyosarcoma cell line) were used as 
positive control.  
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DISCUSSION 
 
 
 
Amyotrophic Lateral Sclerosis (ALS) represents one of the most common 
form of adult-onset Motor Neuron Diseases (MND), characterized by 
progressive muscle weakness caused by gradual degeneration of upper and lower 
motor neurons (MNs) [66]. MNs degeneration and muscle atrophy are the major 
pathological process associated with ALS, suggesting that nerve activity plays an 
extremely important role in muscle homeostasis and remodeling. However, 
whether muscle atrophy in ALS patients is independent from MNs degeneration 
or results from it remained to be defined. A direct influence of skeletal muscle 
tissue on pathogenesis in mouse models of ALS has recently been demonstrated 
[68, 76]. Nonetheless, little is known about the role of muscle Satellite Cells 
(SCs) in ALS patients. Therefore, in this study we wanted to understand why 
skeletal muscle regeneration process in patients affected by ALS results 
insufficient leading to severe muscle atrophy and loss of strength. 
We established quite pure primary muscle cells culture (≥ 60% desmin+) from 
SCs isolated from 3/7 ALS patients and 3/3 aged-matched healthy control. The 
reason why we were not able to isolate or expand SCs from the other 4 ALS 
patients can be due to the small amount of human muscle biopsies, which is 
critical in order to obtain successful primary myoblasts cells culture [110]. 
Moreover, the establishment of pure muscle cell cultures in some case failed for 
the massive presence of other cell types, such as fibroblasts which may affected 
the small number of myogenic cells. The primary function of SCs is to ensure 
skeletal muscle maintenance, repair and regeneration [14]. Therefore, their 
activation,  proliferation and differentiation are important process in order to 
preserve skeletal muscle structure and function. It remains unclear why the pool 
of SCs in denervated muscle does not compensate for the loss of muscle mass 
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during post-denervation atrophy. In our study, we observed that SCs derived 
from ALS patients give rise to myoblasts which possess higher capacity to 
proliferate in vitro compared to aged-matched control. These results may reflects 
the intrinsic character of SCs in ALS patients muscle. Indeed, SCs can be 
continuously activated in order to counteract skeletal muscle degeneration due to 
denervation leading to the exhaustion of the SCs pool. Several studies on rat 
model showed that denervation causes accelerated SCs activation [111], but long 
term denervation leads to exhaustion of the SCs pool in rat muscle [112]. 
In contrast to our result, Pradat et al (2011), found that human ALS myoblasts 
cultures showed abnormal morphological features defect in proliferation, and 
cellular senescence after 20 divisions [82]. These discrepancy may be related to 
several factors such as the disease status of patients, or different type of muscle 
used to isolate SCs. We did not observe any significant morphological change 
which was synonymous of cellular senescence in proliferating ALS myoblasts. 
Moreover, when we analyzed ALS myoblasts at the TEM, we noticed that, 
compared to aged-matched healthy control, they are still in an undifferentiated 
state characterized by few SR and a mass of rudimentary myofibrils.  
The progression through the myogenic process is finely regulated by a 
complex interaction between MRFs which specifically activate the transcription 
of key muscle genes [32]. We found that ALS myoblasts show alteration in the 
control of lineage progression by MRF which can explain their incapacity to 
properly differentiate. The transcription profile of ALS myoblasts show that 
these cells are in a more committed state given that Pax7 gene expression is 
lower and MyoD is significantly upregulated. MyoD interacts with cell cycle 
regulators, in order to drive the cell proliferation towards differentiation at G1, 
regulating the transcription of downstream MRFs, such as Myogenin [83, 113]. 
Therefore, MyoD upregulation can regulate the increased proliferation of ALS 
myoblasts in combination with other cell cycle genes. However, the 
ultrastructural study of ALS myoblasts show that these cells are still more 
immature compared to healthy aged-matched controls. Moreover, the increased 
expression of MyoD does not correspond to increased Myogenin mRNA and 
protein level during the differentiation, as well as MHC, which is significantly 
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low expressed in ALS myotubes. Therefore, several molecular and 
pathophysiological defects may contribute to alter the molecular signature in 
ALS myoblasts. Indeed, the differentiation program of ALS myoblasts seems to 
be partly affected. We observed differentiated cells with fully formed myofibrils, 
SR and electron-dense Z line. However, part of differentiating ALS myoblasts 
seems to go through degenerative process such as apoptosis or necrosis, which 
can be due in part to the altered regulation of the myogenic program or ALS 
pathological mechanisms.  
Our study shows that ALS myoblasts were able to proliferate in vitro, but 
possess defective differentiation leading to the formation of thinner myotubes, 
characterized in some case by degenerative aspects. The cause of these 
dysfunction is still unknown. Future experiment will be useful to determine 
whether SCs defects in ALS muscle regeneration may be considered as part of a 
non cell autonomous process. Therefore, we will increase the number of patients 
and consider also patients affected by other neuromuscular disease. Moreover, it 
will be interesting to study and identify growth factors or cytokines which are 
involved in the regulation of ALS myoblasts that can affect their capacity to 
growth and differentiate. All these studies, coupled with animal models, will 
clarify our findings. 
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EXPERIMENTAL PROCEDURES 
 
 
 
SCs ISOLATION AND MYOBLASTS PRIMARY CULTURE 
Samples were obtained from biopsies of vastus lateralis muscle of 7 ALS 
patients and 3 healthy aged-matched patients as control (Ctrl) submitted to an 
arthroprothesis of the hip. The study protocol was approved by our institutional 
ethics committee. All patients gave their informed consent to the procedure. A 
small muscle tissue sample (20–370 mg) was taken without the use of 
electrocautery. The muscle samples were then plunged into cold (4°C) phosphate 
buffered saline (PBS) or Dulbecco’s Modified Essential Medium (DMEM) plus 
5% penicillin and streptomycin (Sigma-Aldrich, St Louis, MO, USA) and 
immediately transferred to the laboratory or kept at 4°C for a maximum of 48 
hours before processing. The muscle samples were processed as previously 
described (Corbu et al, 2010). Briefly, the muscle biopsies were weighed and 
washed several times with M1, and then finely minced with scissors and 
incubated at 37°C with 5% of CO2 with pronase (Sigma-Aldrich) (0.1% w/v) for 
1 hour under gentle shaking. After the digestion step, the SCs were dissociated 
from the tissue by spinning for 1 minute at 950 g. The supernatant was 
precipitated by spinning for 5 minutes at 1500 g. The pellet was resuspended and 
vigorously triturated with a 10 ml pipette in DMEM plus 10% foetal bovine 
serum (FBS), 1% penicillin and streptomycin two or three times in order to 
dissociate the residual SCs in the tissue. Thereafter, the cellular suspension was 
left to rest for a few minutes and the supernatants were passed through a nylon 
filter (40um) to remove cellular debris and processed for culturing. The cell 
suspension was plated in 2 cm2 dishes coated with type I collagen (Sigma-
Aldrich) in growing medium (GM) which is made up of Ham’s F10 (Sigma-
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Aldrich), DMEM (1 : 1), 15% FBS, 10% horse serum (HS) and 0.006 mg/ml 
basic fibroblast growth factor (bFGF) (Sigma-Aldrich) to stimulate proliferation 
and maintained in an incubator at 37°C with 5% CO2. In order to look at 
myogenic differentiation, cells at 80-90% of confluence, were switched to a 
differentiating medium (DM) made up of DMEM supplemented with 2% FBS 
and 1% antibiotics, to allow myotubes formation. The myogenicity and the 
purity of the culture were determined analysing desmin expression by 
immunocytochemistry (clone D33, Dako, Glostrup, Denmark). 
 
 
IMMUNOFLUORESCENCE AND IMMUNOCYTOCHEMISTRY 
Immunofluorescence staining was performed in LabTek Chamber Slides 
(Nunc, Thermo Fisher Scientific) where cells had been seeded at a concentration 
of 3x103/well. Cells were fixed with 2% Paraformaldehyde (PFA) for 10 minutes 
at room temperature (RT), briefly washed twice with PBS and permeabilized 
with 0.2% Triton X-100/PBS (PBSTx) for 5 minutes at RT. After three washes 
in PBS, cells were saturated for 30 min with blocking buffer (1% bovine serum 
albumin [BSA]) and incubated for 1 hour with primary antibody at 37°C in 
blocking buffer. Secondary antibody incubation was done for 1 hour at 37°C. 
Then cells were mounted with ProLong Gold antifade reagent with DAPI 
(Invitrogen; UK). Different fields for each slides were observed with a 
fluorescence microscope coupled with a digital camera. The fusion index was 
analyzed by myosin heavy chain (MHC) staining using rabbit anti-skeletal 
myosin (Sigma, USA, 1:10 in BSA 1% PBS), with Alexa-fluor 488/430 
secondary antibody (Pierce 1:500). For immunocytochemistry analysis cells 
were grown on plastic coverslips of 13 mm in diameter, fixed in ice cold 
methanol for 10 minutes, then incubated with mouse anti-human desmin 1/200 
(clone D33, Dako), mouse anti-human Ki67 1/50 (Dako) and further incubated 
with a rabbit EnVision anti-mouse peroxidase secondary antibody (Dako). Then 
cells were incubated with 3,3-diaminobenzidine (DAB) for 5 minutes, 
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counterstained with hematoxylin and mounted with DPX mountant for 
microscopy (BDH, Laboratory Supplies, Poole, UK). 
 
 
ELECTRON MICROSCOPY 
Cell cultures were washed with 0.01 M PBS, fixed with 2.5% glutaraldehyde 
in 0.1 M phosphate buffer (pH 7.4) and post-fixed with 1% osmium tetroxide in 
cacodylate buffer. All samples were dehydrated and detached from the plastic 
dish with propylene oxide, centrifuged and embedded in araldite ultrathin 
sections, stained with uranyl acetate and lead citrate and observed with a Philips 
400T Transmission Electron Microscope. 
 
 
RNA EXTRACTION AND QUANTITATIVE REAL TIME PCR 
Total RNA was extracted using Trizol® reagent (Invitrogen, UK) according 
to the manufacturer’s instructions and then reverse transcribed using an RNA 
polymerase chain reaction (PCR) commercial kit (MLV reverse transcriptase; 
Invitrogen). The procedure was conducted according to the manufacture protocol. 
Quantitative Real-Time PCR was performed using PowerSYBR Green PCR 
Master Mix (Applied Biosystems, USA) on ABI Prism® 7700 Sequence 
Detection System/Gene Amp (Applied Biosystems, USA). Relative levels of 
target genes were normalized on the expression of human beta-actin. The cycling 
protocol provides an initial step of 50°C for 2 minutes and 95°C for 10 minutes, 
followed by 40 cycles of 95°C for 15 seconds and 60°C for 1 minute. Genes 
expression was estimated using the relative cycle threshold (Ct) method.  
Real-time PCR Primers:  
Myod Fw cactacagcggcgactcc, taggcgccttcgtagcag;  
Myf4 Fw cagctccctcaaccaggag, Rev gctgtgagagctgcattcg;  
Mhc-1 Fw tttaaggtcgcatctctacgc, Rev aaatggccatctcagagtcg; 
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Pax-7 Fw cactgtgaccgaagcactgt, Rev ctccttcttgtccgcttca; 
Beta-Actin Fw cctggacttcgagcaagagatg, Rev ggaaggaaggctggaagagtg 
 
 
WESTERN BLOT 
For Western blotting analysis cells harvested were lysed in ice-cold buffer 
(Tris-HCl 0,01M pH 7.6, NaCl 0,1M, Triton X-100 0,1% , EDTA 0,001M pH 8, 
PMSF 1 mM, DTT 1 mM 50X ,Na3VO4 1 µM) supplemented with protease and 
phosphatase inhibitors cocktail (complete 2x , Roche, Italy). After 30 minutes of 
ice-incubation, samples were centrifuged for 15 minutes at 13,000 rpm and 4°C 
to remove insoluble debris. Proteins in the supernatants were quantified by 
Lowry assay. 50 µg of sample proteins were mixed 1:4 with Laemmli sample 
buffer (Tris-HCl pH 6.8 60 mM, 2% SDS, 5% glycerol, 2,5% β-mercaptoethanol 
and 0,01 % bromophenol blue) and heated at 95°C for 5 minutes. Protein extracts 
were separated by 10 % SDS-polyacrylamide gel and then transferred to 
nitrocellulose membranes for immunoblotting. Blots were blocked for 1hour 
with blocking solution (BS) (TBS-T 3% Milk 1,5% BSA) and probed with the 
specific primary antibodies: mouse anti-MyoD (Dako, USA; 1/200 in BS), 
mouse anti-Myogenin (Santa Cruz Biotech, U.S.A; 1/200 in BS) overnight at 
4°C. A mouse anti-β-Actin antibody (Santa Cruz Biotech, U.S.A; 1:500 in BS) 
was used as expression control for total extracts. 
 
 
STATISTICAL ANALYSIS 
Experiments were performed in triplicate and means and standard deviation 
was calculated. A student’s T test was employed to determine statistical 
significance. P<0.05 was considered statistically significant. 
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RESULTS 
 
 
 
P16Ink4a drives the expansion of proliferating myogenic cells both in adult 
and aged mice 
The regenerative ability of skeletal muscle relies on the population of 
Pax7+SCs. Following injury SCs are activated, as myoblasts, and undergo rapid 
proliferation starting approximately at 2 days after injury. Then, they 
differentiate and fuse to form new muscle fibers. A small percentage of 
proliferating SCs self-renew and reconstitute the SC pool [35]. The cell cycle 
inhibitor P16ink4a has been considered as an important tumor suppressor 
functioning as a mediator of cellular senescence and its role has been associated 
with the regulation of stem/progenitor cell function in different tissue during 
aging [92, 94, 97-98]. Here, we characterized the expression of P16ink4ain SCs 
and their progeny. We first examined P16ink4a transcript level in myoblasts (MB), 
reserve cells (RC) and myotubes (MT) in vitro (Figure 1B, C). P16ink4a transcript 
levels were higher in proliferating MB, compared to RC and MT. P16Ink4a 
transcript correlates with protein level as shown from Western Blot analysis in 
MB, RC and MT (Figure 1C). P16ink4a expression has been found to increase 
with aging in different mammalian tissue [92]. We next investigated P16ink4a 
transcript levels during regeneration in adult and aged mice. Tibialis 
Anterior/Extensor Digitorus Longus (TA/EDL) muscle from adult and aged mice 
was injected with 50µl of 1.2% barium chloride (BaCl2) and allowed to 
regenerate from 2 to 30 days. Myogenic cells were obtained by Fluorescent-
Activated Cell Sorting (FACS) from uninjured and regenerating adult muscle 
(Figure 1A). Compared to uninjured muscle, P16ink4a expression was 
significantly increased at 2 days of regeneration, when SCs are proliferating, and 
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then decreased as regeneration progressed, when most myogenic cells are 
differentiating (6, 13 days) and non-cycling (30 days). P16ink4a levels, as 
expected, were found to be slightly increased in aged myogenic cells compared 
to adult (Figure 1D). Therefore P16ink4a expression in myogenic cells is 
temporally regulated and correlates with proliferative phase of regeneration in 
vivo. To test the role of P16ink4a during myogenesis in vitro and in vivo we used 
P16ink4a  knock out (P16 Null) adult and aged mice. Initially, we tested whether 
absence of P16ink4a affects SC progenitor cell proliferation. Cultured myogenic 
cells, obtained by FACS from adult and aged muscle, were counted and 
compared to adult and aged wild type (WT). In absence of P16ink4a adult and 
aged myoblasts showed increased growth rate (Figure 1E). Moreover, single 
fibers cultured for 48 hours and pulsed with BrdU, confirmed that loss of 
P16ink4a significantly increase the percentage of cycling transient amplifying 
myogenic progenitors cells (TAC) (Pax7+, BrdU+) both in adult and aged 
compared to WT adult and aged control (Figure 1F). We next asked whether the 
rapid expansion of P16 null myoblasts affected the generation of fusion 
competent myogenic cells. Myogenic cells from adult WT and P16 Null were 
cultured for 6 days in growing condition and then switched to low-mitogen 
media for 3 days. P16 Null myoblasts were able to form numerous 
multinucleated myotubes as the WT (Figure 1G). Together, these data suggest 
that P16ink4a expression is restricted to activated SCs and that loss of 
P16ink4a increase the proliferation of myoblasts, but does not prevent 
differentiation.  
 
 
Loss of P16Ink4a rescues the pool of early progenitors and defective 
regeneration in aged muscle  
During aging there is a gradual functional decline in muscle SCs and their 
capacity to repair muscle [59, 114]. Pax7 is a marker of adult SCs and is required 
for the formation of adult SCs pool [21]. The majority of Pax7+/MyoD+ activated 
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TAC cells progress towards the differentiation program characterized by 
downregulation of Pax7 and upregulation of Myogenin [14]. Therefore, based on 
myogenic lineage markers, we asked whether adult and aged P16 Null myogenic 
progenitors were enriched for a TAC character. Single muscle fibers suspension 
culture from adult and aged WT and P16 Null mice were stained and analyzed 
for the number of Pax7+ and Myogenin+ cells, as a readout of early and late 
lineage respectively. Our results show a reduction of Pax7+ cells in aged versus 
adult WT. In P16 Null adult and aged muscle fibers there was an expansion of 
Pax7+ cells at expense of Myogenin+ cells compared to WT cultures. 
Significantly, in P16 Null aged fibers the pool of Pax7+ cells was restored to 
adult WT level (Figure 2A). Therefore, during aging the absence of P16Ink4a 
enriches the pool of Pax7+ cells. To test the role of P16Ink4a in vivo during 
skeletal muscle regeneration, TA/EDL muscles from adult and aged WT and P16 
Null were injected with 50µl of 1.2% BaCl2. Control and regenerated muscles 
were collected and analyzed after 6 days of regeneration. Uninjured muscles 
were morphologically similar between WT and P16 Null mice (data not shown). 
Immunohistochemical analysis of the 6 days regenerating TA revealed an 
increase of the number of cycling (Myod+/Ki67+) Pax7+ cells in absence of 
P16Ink4a both in adult and aged (Figure 2B). Moreover formation of new 
myofibers was enhanced in adult and aged regenerating P16 null muscles 
compared to age matched controls. Significantly loss of P16Ink4a function in aged 
muscle rescued fiber formation to levels of adult WT controls (Figure 2C). 
Together these results demonstrate that P16Ink4a loss during aging increases the 
number of Pax7+ cells and rescues defect in aged myofibers formation. 
 
 
SC specific P16Ink4a inactivation alters myoblast proliferation independent of 
senescence  
To bypass potential caveats associated with germline deletion of genes we 
used a Pax7CreERtm; P16Ink4a flox/flox and tested the role of P16Ink4a in Pax7+ SCs 
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[35, 115]. The P16Ink4a conditional allele has a floxed sites flanking exon 1α of 
the Ink4a/Arf locus and somatic excision of P16Ink4a does not alter expression of 
P15Ink4b or ARF (Figure 3A, 5A), in contrast to germline P16Ink4a inactivation 
[115]. Deletion of P16Ink4a can be achieved in vitro with Adenovirus-Cre 
infection to target loxP sites. Myoblasts were isolated from Pax7CreERtm; 
P16Ink4a flox/flox mice and infected with Ad5CMV-eGFP (Ctrl) and Ad5CMVCre-
eGFP (P16f/f) (Figure 3A). With this approach we were able to target the 
P16Ink4a deletion in SCs progenitor in vitro, resulting in an approximately a 95% 
efficiency of infection and P16Ink4a deletion, based on GFP expression (Figure 
3B). First, we examined if specific deletion of P16Ink4a in SCs progenitors affect 
their proliferation ability. Twenty-four hours after infection, Ctrl and P16f/f 
myoblasts were pulsed with BrdU (5uM) for12 hours and analyzed at 12, 24 and 
36 hours (Figure 3C). The growth curve and number of Pax7 cells that 
incorporate BrdU revealed that in absence of P16Ink4a Pax7+ progenitors cells 
maintain the capacity to proliferate more compared to Ctrl, in agreement with the 
P16Ink4a null germline model (Figure 3C, 1E). P16Ink4a has been implicated as 
mediator of cellular senescence [109]. Therefore, to test whether the proliferative 
advantage gained by P16f/f myoblasts was due to changes in cellular senescence, 
we performed a SA-β-galactosidase assay. Unlike a positive control for 
senescent embryonic stem cells, (Mouse Embyonic Fibroblasts, MEFs), Ctrl and 
P16f/f cultures were negative for SA-β-galactosidase expression (Figure 3D). 
Therefore, acute deletion of P16Ink4a specifically in SCs increased the rate of 
proliferating SC progenitors in absence of cellular senescence. 
 
 
SC P16Ink4a deletion alters myogenic fate decisions  
Given that loss of P16Ink4a increased the proliferation rate of SC progenitors 
we wanted to evaluate their progression through the myogenic program. In 
particular we expected that P16f/f myoblasts were enriched for a TAC 
(Pax7+/MyoD+). Indeed, 48 hour after adenovirus infection P16f/f myoblasts 
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showed expansion of Pax7+/MyoD+ cells with also a slight increase in the pool 
of reversibly quiescent Pax7+/MyoD- cells compared to Ctrl (Figure 4A). Next, 
as in the P16Ink4a knockout model, we investigate their capacity to differentiate. 
Twenty-four hours after adenovirus infection, Ctrl and P16f/f myoblasts were 
switched to low-mitogen media and left to differentiate for 3 days. 
P16f/f myoblasts were able to progress through the differentiation program, 
forming multinucleated myotubes (Figure 4B). These in vitro experiments 
confirm the results obtained with the P16Ink4a knockout model. Therefore, acute 
deletion of P16Ink4a in myoblasts expands the Pax7+/MyoD+ pool. Moreover, this 
enriched population of proliferating myoblasts is able to differentiate and fuse to 
form multinucleated myotubes. 
 
 
SC specific P16Ink4a inactivation affects cell cycle regulators and MRFs 
expression 
P16Ink4a activation is regulated at the transcriptional level by MAPK signaling 
via ERK and p38MAPK [87]. Moreover, this signaling pathway is involved in 
the modulation of other cell cycle regulators that may contrast and/or cooperate 
with P16Ink4a activity [87]. We studied the effect of P16Ink4a deletion on the 
expression of other cell cycle regulators in relation to the control of myogenic 
lineage progression by MRFs. We performed a Mouse MAP Kinase Signaling 
RT² Profiler™ PCR Array that profiled the expression of 84 genes related to the 
MAP Kinase signaling pathway (Figure 5A). The PCR array was done on Ctrl 
and P16f/f myoblasts 18 hours after adenovirus infection. Among all the genes 
evaluated we focused our attention on the most significative genes related to the 
G1 cell cycle phase regulation. Then, we validated the array analyzing the 
transcript level of P16Ink4a, Cdkn1b (p27), Cdkn1a (p21), Ccnd1 (Cyclin D1) and 
Cdkn1C (p57) (Figure 5 B). After 18 hours recovery from Cre infection P16Ink4a 
levels were reduced by  ̴ 60% compared to Ctrl. Nonetheless, partial deletion of 
P16Ink4asignificantly affected the expression of other cell cycle genes. p27, p21, 
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p57 belongs to the Cip/Kip CKIs inhibitors that specifically bind to and block the 
activity of CDK2 complex. However, Cip/Kip members can associate with 
CDK4/6 and have a stimulatory effect by promoting the assembly of the active 
cyclin–CDK complex [116]. p21 and p57, but not p27, are significantly 
upregulated in absence of P16Ink4a, as well as Cyclin D1. Next, we analyzed the 
MRFs transcript profile. Significantly, loss of P16Ink4a decreases Myf5 and 
Myogenin, upregulating Pax7 and MyoD transcript level (Figure 5B). This was in 
accordance with the lineage progression analysis where we observed expansion 
of Pax7+/MyoD+ TAC in the absence of P16Ink4a.. Therefore, these results 
demonstrate that Cyclin D1 and Cip/Kip CKI cell cycle inhibitors are sensitive to 
P16Ink4a deletion and are transcriptionally activated. Moreover, these changes on 
cell cycle gene expression are reflected in regulation of MRFs, confirming that 
loss of P16Ink4a contributes to downregulate Myogenin and Myf5, promoting the 
expression of Pax7 and MyoD.  
 
 
CDK4/6 inhibition partially restores the effect of P16Ink4a deletion 
P16Ink4a prevents cell cycle progression during G1 phase through its binding 
to CDK4/6 and inhibiting CDK4/6-mediated phosphorilation of pRB [87]. 
Therefore, we hypothesized that the inhibition of CDK4/6 should rescue the 
effect caused by P16Ink4a deletion in SC progenitors. After adenovirus infection, 
myoblasts from Ctrl and P16f/f were incubated for 18 hours with Cdk4/6 inhibitor 
(5µM) and then collected for mRNA and protein analysis (Figure 6A). Ablation 
of P16Ink4a resulted in ̴ 90% loss of P16Ink4a protein (Figure 6B, C). Cdk4/6 
rescued the expression of p21, p57 and Cyclin D1, but it did not affect P16Ink4a, 
which seemed to be independent from the CDK4/6 inhibition. Of note, p27 was 
upregulated when CDK4/6 was added both in Ctrl and in P16f/f myoblasts 
(Figure B, C). We also analyzed MRFs expression after CDK4/6 inhibition. In 
Ctrl myoblasts inhibition of CDK4/6 caused a block of cell cycle, given that all 
MRFs were downregulated. However, CDK4/6 did not rescue MRFs transcript 
and protein level in absence of P16Ink4a (Figure B, C). Therefore, the effects of 
P16Ink4a loss on cell cycle genes regulation are rapidly rescued by CDK4/6, 
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confirming that P16Ink4a acts through the CDK4/6/Cyclin D1 pathway. However, 
MRFs regulation is controlled by CDK4/6 and other independent mechanisms.  
 
 
SC specific deletion of P16Ink4a enhanced progenitor expansion 
To directly test the role of P16Ink4a in Pax7+ SCs and their progeny in vivo, we 
used the Pax7Cre ERtm;P16Ink4a flox/flox mouse model (P16f/f) to permanently 
disrupt P16Ink4a function in adult Pax7+ SCs upon tamoxifen (TM) administration  
[35, 117] (Figure 7A). Pax7Cre ERtm-;P16Ink4a flox/flox mice treated with TM were 
used as controls (Ctrl). It has previously been demonstrated that Pax7Cre allele 
or TM treatment at the dosages used in these studies do not affect SC function 
and muscle regeneration [35]. In the present studies, four days after TM 
administration, single fibers were isolated from Ctrl and P16f/f adult mice and 
cultured for 0, 2 and 3 days. Using Pax7 and Myogenin as lineage markers, we 
investigated if loss of P16Ink4a modifies the proportion of myogenic progenitors 
at an early (Pax7+/Myogenin-) versus late (Pax7-/Myogenin+) stage of lineage 
progression. We observed in P16f/f mice that the number of Pax7+ cells along 
single muscle fibers gradually increased and was significantly higher than the 
Ctrl after 3 days of suspension culture (Figure 7B, C), without any significant 
change in Myogenin+ cells number, as observed in the P16Ink4a knockout model 
(Figure 7D). Therefore, these results show that acute P16Ink4a deletion in SCs 
results in a greater expansion of the pool of early progenitor Pax7+ cells.  
 
 
Bmi1-GFP+ correlates with the expansion of Pax7+ SCs 
Bmi1 gene belongs to the PcG family and is a component of the polycomb 
repressive complex 1 (PRC1) that is implicated in the stable maintenance of gene 
repression [118]. Bmi1 has been reported to epigenetically silence the 
Ink4a/ARF/Ink4b locus [119-120]. Additionally, extensive analysis reported that 
Bmi1 is essential for the maintenance of normal adult HSC and leukemia stem 
cells as well as adult NSC [103-104, 121]. We used targeted reporter mice in 
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which the endogenous Bmi1 gene was replaced through homologous 
recombination with GFP [122] as an alternative approach to dissect the role of 
P16Ink4a in muscle SCs. Myogenic cells were FACS sorted from adult Bmi1-GFP 
mice based on their GFP expression. We first examined the proliferative capacity 
of Bmi1-GFP+ (High) and Bmi-GFP- (Low) myogenic cells. Bmi1-
GFP+ myogenic cells showed increased growth rate after 7 days in culture, which 
is maintained also after serial plating. On the contrary, Bmi1-GFP- myogenic 
cells stopped growing after serial plating. Given that Bmi1 suppress P16Ink4a, 
Bmi1-GFP+ (P16Ink4a low) showed increased proliferation as in P16Ink4a knock 
out and Pax7CreERtm; P16Ink4a flox/flox mice models. Bmi1-GFP- (P16Ink4a high) 
may stop cycling because they start to differentiate or becoming senescent. 
Bmi1-GFP+ marks stem or progenitors cells in non-hematopoietic tissues [122]. 
Thus, we analyzed Bmi1-GFP and Pax7 expression on single fibers isolated from 
adult mice and cultured for 48 hours. Our results showed that Pax7 expression 
correlated with Bmi1-GFP+ and that the number of Pax7+/Bmi1-GFP+ increased 
after 48 hours, but not Pax7+/Bmi1-GFP- cells, which remained Bmi1-GFP-. 
Therefore, these finding confirm that Bmi-1 controls P16Ink4a expression. Indeed, 
Bmi1-GFP+ regulates the expansion and probably the self-renewal of Pax7+ SCs, 
possibly by restricting P16Ink4a . Moreover, Bmi1-GFP represents a very 
interesting model to study distinct subpopulation of SCs with differential 
Bmi1/P16Ink4a expression both in postnatal muscle growth and adult muscle 
regeneration. 
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Figure 1. Loss of P16Ink4a increases the proliferation rate of both adult 
and aged myoblasts without affecting their differentiation program 
A. Representative FACS plots of mononucleated cells isolated from TA/EDL 
muscles and stained with propidium iodide (PI), anti-streptavidin VCAM 
biotinylated (APC), anti-α7-Integrin (Pacific Blue), anti-CD31/45 (PE) 
antibodies. Double positive DP cells gated on vcam+/α7integrin+/CD31-/CD45-
/PI- were collected and used for further study of myogenic cells.  
B, C. Transcript and protein level of P16Ink4a expression were assessed 
respectively by real-time qRT-PCR and Western Blot in myoblasts (MB), 
reserve cells (RC) and differentiated myotubes (MT) derived from FACS sorted 
SCs-myogenic cells cultures. 
D. P16Ink4a transcript level was assessed by real-time qRT-PCR from FACS-
purified myogenic cells isolated from uninjured and regenerating TA/EDL 
muscle of adult and aged mice after 2, 6, 13 and 30 days. 
E. Growth curve of purified myoblasts isolated from P16Ink4a WT and Null adult 
and aged mice. The total number of cells after 24, 72, 120, 168 hours in culture 
was plotted relative to the initial cell number at 0 hour (n = 3). 
F. The percentage of BrdU+ myogenic cells in single fibers isolated from P16Ink4a 
WT and Null adult and aged BrdU-treated mice after 48 hours of culture.  
G. Primary myoblasts from P16Ink4a WT and Null adult mice were switched to 
low-mitogen media for 3 days and stained for eMHC (green) in order to assess 
their capacity to differentiate in vitro. 
Experiments done in triplicate. Data presented as mean and SEM, n = 4-6 mice 
(p < 0.05). 
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Figure 2. Absence of P16Ink4a restores the pool of early progenitors in 
aged muscle and rescues defect in aged myofibers formation. 
A. Single fibers, isolated from P16Ink4a WT and Null adult and aged mice, were 
cultured for 3 days and stained and quantified for Pax7 (red) and Myogenin 
(green) positive cells per single muscle fiber. 
B. Transverse sections of regenerating TA muscle from P16Ink4a WT and Null 
adult and aged mice, were stained for cycling (MyoD+, Ki67+, red) Pax7+ cells 
(green) located in sublaminar position (laminin+; magenta). Quantification of the 
total number of cycling Pax7+ cells per muscle section (left). 
C. H&E staining of transverse section of regenerating P16Ink4a WT and Null, 
adult and aged TA muscle and quantitative analysis of myofiber number 
expressed in percentage (%), normalized to uninjured control muscle. 
Data presented as mean and SEM, n = 4-6 mice. 
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Figure 3. In vitro specific SCs P16Ink4a inactivation results in increased 
myoblasts proliferation rate which occurs in absence of cellular senescence. 
A. Cartoon depicting the adenovirus infection strategy to induce Cre 
recombination activity in myoblasts obtained from Pax7-CreERtm;P16flox/flox adult 
mice.  
B. Representative images of Pax7-CreERtm;P16flox/flox myoblasts infected with 
Ad5CMV-eGFP control (Ctrl) and Ad5CMVCre-eGFP (P16f/f) (GFP, green). 
Efficiency of infection based on GFP expression expressed as a percentage (%) 
(left). 
C. Growth curve of Ad5CMV-eGFP control (Ctrl) and Ad5CMVCre-eGFP 
(P16f/f) infected myoblasts from Pax7-CreERtm;P16flox/flox adult mice pulsed with 
Brdu (5µM) in PM for 12 hours and fixed at 12, 24 and 36 hours (cartoon). The 
total number of growing cells per field and the number of Pax7+/Brdu+  cells 
after 12, 24, 36 hours was quantified.  
D. Bright field images and quantification of infected myoblasts from Ad5CMV-
eGFP control (Ctrl) and Ad5CMVCre-eGFP (P16f/f) infected myoblasts from 
Pax7-CreERtm;P16flox/flox adult mice stained for SA-β-galactosidase. Serial 
passaged Mouse Embryonic Fibroblasts (MEFs) cultures were used as positive 
control. Blue arrows indicate SA- SA-β-galactosidase+ cells. 
Data are presented as mean ± SEM, n = 3, p < 0.05. Scale Bars represents 50 µm. 
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Figure 4. In vitro SC-specific P16Ink4a inactivation results in the 
expansion of the fusion competent Pax7+MyoD+ progenitors pool. 
A. After 24 hours Ad5CMV-eGFP control (Ctrl) and Ad5CMVCre-eGFP (P16f/f) 
infected myoblasts from Pax7-CreERtm;P16flox/flox adult mice were stained for 
Pax7 (red), MyoD (white), Dapi (blue). Pax7+MyoD- and Pax7+/MyoD+ cells 
were quantified as mean of 10 independent microscope fields (Pax7+MyoD-, red 
arrows; Pax7+MyoD+ yellow arrows; Pax7-MyoD+, green arrows) 
B. Ad5CMV-eGFP control (Ctrl) and Ad5CMVCre-eGFP (P16f/f) infected 
myoblasts from Pax7-CreERtm;P16flox/flox adult mice were switched after 48h in 
growing condition to low-mitogen media and their capacity to fuse was assessed 
by MHC staining (red). 
Data presented as mean ± SEM; n = 3; p < 0.05. Scale bar represents 50 µm. 
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Figure 5. Effect of loss of P16Ink4a in Pax7+ progenitors cells on cell 
cycle gene regulators and MRFs 
A. Gene expression analysis of Ad5CMV-eGFP control (Ctrl) and Ad5CMVCre-
eGFP (P16f/f) infected myoblasts from Pax7-CreERtm;P16flox/flox mice was 
examined with a PCR-array focused on the MAP Kinase signaling pathaway. 
Putative targets of P16Ink4a are highlighted: Cdkn1c (p57) (red), Ccnd1 (CyclinD1) 
(red), Cdkn1a (p21) (yellow), Cdkn2a (p16) (green), Cdkn1b (p27) (green).  
Data presented as mean of value obtained from a duplicate experiment. 
 
B. Transcript levels of p16, p27, p21, p57, CyclinD1, Pax7, Myf5, MyoD and 
Myogenin were validated by real-time qRT-PCR from Ad5CMV-eGFP control 
(Ctrl) and Ad5CMVCre-eGFP (P16f/f) infected myoblasts isolated from Pax7-
CreERtm;P16flox/flox mice.  
Data presented as mean ± SEM, n = 3, p <0.05. 
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Figure 6. P16Ink4a inactivation effects are partially restored by Cdk4 
inhibitor, confirming the P16Ink4a downstream regulation. 
 
A. Cartoon depicting the experimental design of adenovirus infection strategy to 
induce Cre recombination in myoblasts obtained from Pax7-
CreERtm;P16flox/flox adult mice.  
B. Transcript levels of p16, p21, p27, CyclinD1, p57 (right) and Pax7, Myf5, 
MyoD, Myogenin (left) from Ctrl and P16f/f  myoblasts treated with Cre and 
Cdk4 inhibitor were assessed by real-time qRT-PCR. 
C. Protein level of Pax7, Myf5, MyoD, Myogenin, p16 and CyclinD1 were 
analyzed by Western Blot 18 hours after Cre and Cdk4 inhibitor treatment. 
Data presented as mean ± SEM; n = 3; p < 0.05. 
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Figure 7. P16Ink4a deletion from SCs in vivo increases the pool of 
progenitors cells without affecting myogenic progression. 
A. Cartoon depicting the tamoxifen (TM) injection scheme for P16Ink4a deletion 
in Pax7-CreERtm/P16flox/flox. 
B, C, D. Single fibers isolated from Pax7-CreERtm/P16wt/wt (Ctrl) and Pax7-
CreERtm/P16flox/flox (P16f/f), were cultured in suspension for 0, 2 and 3 days and 
stained and quantified for Pax7 (red) and Myogenin (green) positive cells . 
Data presented as mean ± SEM; n = 3; p < 0.05. 
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Figure 8. Bmi1-GFP+ correlates with the expansion of Pax7+ SCs 
 
A. FACS sorted myogenic cells from Bmi1-GFP adult mice based on the GFP 
expression. 
B. Bright field images of cultured Bmi1-GFP+ and Bmi1-GFP- FACS sorted 
myogenic cells from adult Bmi1-GFP mice. Growth curve of Bmi1-GFP+ and 
Bmi1-GFP- FACS sorted myogenic cells at P0 and P1 passages. The total 
number of cells was plotted relative to the initial cell number at 0 day. 
C. Single fibers isolated from Bmi1-GFP adult mice were cultured for 0 and 48 
hours and stained and quantified for Bmi1-GFP (green) and Pax7 (red) positive 
cells per single fiber. 
Data presented as mean ± SEM; n = 3; p < 0.05. Scale bar represents 50µm. 
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DISCUSSION 
 
 
 
P16Ink4a represents one of the most important CKIs during G1 cell cycle 
progression. Acting as a tumor suppressor gene, P16Ink4a inhibits cell cycle 
preventing uncontrolled cancer cells proliferation and inducing cellular 
senescence [123]. Its expression rises with age in many tissues, correlated with 
the accumulation of dysfunctional senescent cells [124-125]. Recently, P16Ink4a 
has been involved in the decline of the replicative capacity of different stem cell 
compartments, such as HSCs, NSCs and pancreatic β-cells [94, 97-98]. How 
P16Ink4a promotes aging, limiting proliferation and self-renewal, remains still 
unclear and more studies are necessary to clarify if it happens through increase 
of senescence, block of cell cycle or other mechanisms. The role of P16Ink4a in 
skeletal muscle stem cell biology has never been investigated. Our work 
highlights a novel role of P16Ink4a in adult skeletal muscle stem cells, a role that is 
independent of senescence or aging. In the present study, we demonstrated that 
P16Ink4a is expressed in activated and proliferating satellite cells (SCs). Whether 
P16Ink4a expression is confined to a particular subpopulation of myogenic cells or 
it is expressed at low levels by all cells, it is still not clear. After damage, 
Pax7+SCs are rapidly activated to initiate the myogenic program, differentiate 
and eventually, form new muscle fibers and replenish the pool of SCs [35]. We 
found that P16Ink4a expression is temporally regulated during in vivo regeneration 
and correlates with the activation of SCs after 2 days of regeneration and 
confirmed in proliferating myoblasts. Then its expression declines as soon as 
myogenic cells differentiate or go back to quiescence. These data probably 
reflects that P16Ink4a can be activated by signals and growth factors that also 
regulate activation and proliferation of SCs, such as members of FGF family or 
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Notch signaling pathway [14, 52]. These signals may converge and interact with 
members of the MAP Kinase signaling pathway, which is involved in cell cycle 
regulation and it is often associated with the induction of P16Ink4a  [126]. Future 
studies can clarify and define extrinsic signals that modulate the SCs niche and 
therefore, regulate their activity and the regulation of P16Ink4a . 
In this study we used different approaches to define the role of P16Ink4a in 
skeletal muscle SCs progenitors. In particular, we analyzed the effect of 
P16Ink4a germline inactivation during skeletal muscle regeneration. However, in 
knockout mice, the inactivation of a gene can be compensated by other 
developmental mechanisms, such as the increased expression of other cell cycle 
inhibitors, for example, P15Ink4b [115]. Therefore, we developed a temporally 
inducible, cell-specific gene deletion approach to directly target 
P16Ink4a expression in Pax7+SCs and their progeny [115, 117]. Germline 
inactivation of P16Ink4a results in increased myogenic cells proliferation. In 
Pax7CreERtm;P16Ink4aflox/flox conditional knockout mice acute deletion of 
P16Ink4a in Pax7+SCs progenitors increases proliferation rate. In addition, 
previous reports demonstrated that the number and proliferative capacity of 
HSCs and NSCs is increased in P16Ink4a null mice [94, 97]. These findings are 
consistent with the role of P16Ink4a as a cell cycle inhibitor. Indeed, reduced level 
of P16Ink4a results in downregulation of Myf5 and Myogenin and increased 
expression of CyclinD1 in Pax7+SCs progenitors, without any significant 
compensatory increase in other CKIs except P57Kip2. P57KIP2 participates in 
myogenesis [127], it stabilizes MyoD protein, through inhibition of cyclin E-
CDK2 complex [128] and in turn, MyoD up-regulates P57Kip2 in a p73-
dependent manner [129]. This suggests that there is a fine balance and 
cooperation between MRFs and cell cycle genes. 
Our results suggest that P16Ink4a controls early myogenic progenitors 
expansion in absence of cellular senescence. This change in proliferation reflects 
changes in SC lineage progression. Thus, P16Ink4a control the lineage progression, 
regulating the expansion of early progenitor cells. We believe from our data that 
the pool of Pax7+/MyoD+ progenitor cells possesses the potential to progress 
through the lineage program. The temporal coordination between proliferating 
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progenitor cells and differentiation is a complex process regulated by multiple 
factors. Notch signaling pathway is required for the activation of SCs in order to 
form rapid cycling TAC progeny [52]. This stage is followed by a coordinated 
increase in Wnt signaling and decreases in Notch signaling, which drives the 
onset of differentiation [54]. Therefore, P16Ink4a can control the expansion of 
early progenitors cells and the balance between extrinsic signaling pathways may 
finely modulate its role.  
Dividing SCs progenitors can generate daughter cells with a more self-
renewal and/or more committed character. Cell fate decision is critical and is 
regulated by symmetric and/or asymmetric cell division mechanisms. However, 
very little is known about SCs asymmetric division mechanisms[130-131]. From 
our data, P16Ink4a seems to not affect the pool of self-renewal Pax7+SCs, but it 
only increases the Pax7+MyoD+ TACs compartment. During in vivo muscle 
regeneration loss of P16Ink4a expands the Pax7+SCs early progenitors pool and 
increases the number of newly-formed myofibers after 6 days of regeneration. 
Therefore, we can only hypothesize a possible role of P16Ink4a in controlling 
asymmetric fate decisions, but this assumption needs more studies. Future in 
vitro experiments (i.e. time lapse microscopy) will contribute to understand the 
role of P16Ink4a during cell division and give new insight into SCs fate decision 
mechanism. In addition, secondary injury in vivo experiments will be performed 
in order to confirm that the increase of early progenitors in absence of P16Ink4a 
does not affect self-renewal of the SC pool. Consistent with previous work on 
the P16Ink4a function during aging [94, 97], we demonstrated that P16Ink4a controls 
the expansion of Pax7+SCs pool in adult mice and more interesting its deletion 
restores the pool of early progenitors in aged mice which display improved 
regenerative capacity. Indeed, the decline in muscle tissue regeneration with 
aging is largely due to a decreased function of Pax7+SCs [132]. Not only, SCs 
activity can be affected by signals change in the aged microenviroment ([114, 
132]. However, deletion of P16Ink4a increases the number of cycling Pax7+SCs 
during regeneration in aged mice and enhances the formation of new myofibers, 
rescuing defective aged myogenesis. Moreover, activation of P16Ink4a has been 
reported to be responsive to extrinsic signals in old mice, such as TGFβ/pSmad3. 
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Activation of Notch signaling pathway blocks TGFβ/pSmad3 dependant 
upregulation of P16Ink4a and restores SCs regenerative capacity [133]. Therefore, 
P16Ink4a function in SCs during aging can be influenced by multiple extrinsic and 
intrinsic factors. 
Consistent with the idea that P16Ink4a drives cell cycle exit through pRb 
hypophorphorylation mediated by CDK4/CyclinD, we asked whether inhibition 
of CDK4 activity would rescue signaling events induced by loss of P16Ink4a. 
Some cell cycle regulators such as p21, p57 and Cyclin D1 are sensitive to 
P16Ink4a deletion and their transcript levels are rapidly restored after inhibition of 
CDK4/6. However, the regulation of MRFs seems to respond only in part to the 
CDK4/6 inhibition, suggesting that their regulation is not only dependent on the 
cell cycle state via CDK4, but many other factors can affect the expression of 
MRFs such as epigenetic [134-135] and post-transcriptional mechanisms [135].  
Cell cycle exit and differentiation are controlled by multiple cell cycle 
regulators. In particular, CKIs as well as pRb family proteins play an important 
role in regulating differentiation [136]. However, we showed that during 
myogenic differentiation P16Ink4a is not required for terminal differentiation. In 
spite of a reduction in Myogenin+ cells in proliferating cultures, when P16Ink4a 
null cells are cultured under low serum conditions, they form myotubes normally, 
suggesting that P16Ink4a is not required for terminal differentiation. Indeed, a 
substantial amount of literature indicates that other CKIs belonging to Cip/Kip 
family cell cycle inhibitors drive cell differentiation. In particular p21Cip has been 
involved in the regulation of myogenic differentiation and p21Cip null mice show 
impaired adult regeneration [137]. However, myogenic differentiation is also 
dependent on pRb family proteins. Indeed, lack of pRb in myoblasts cause 
severe defect of myogenesis and terminal differentiation, while proliferation is 
transiently enhanced [89]. Recently, it has been reported, that in Pax7CreER;Rb1 
conditional mice, the Pax7+SCs pool is expanded, but myogenic differentiation is 
impaired resulting in delayed muscle regeneration in vivo [90]. This work 
supports in part our observations. Nonetheless, we found that P16Ink4a is not 
involved in myogenic differentiation, which seems to be in contrast with pRb 
findings. However, Kotake et al, (2007) showed that pRb family proteins are 
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required for recruitment of PRC2 (Polycomb Repression Complexes) to 
trimethylate P16Ink4a promoter, priming the Bmi-1 containing PRC1L ubiquitin 
ligase complex to silence P16Ink4a [138]. In this context our data from Bmi1-GFP 
mice model supports a role for P16Ink4a in myogenic lineage progression. Using 
Bmi1-GFP knock-in mice model [122], we were able indirectly to dissect the 
role of P16Ink4a , based on the Bmi1-GFP expression. Indeed, SCs derived from 
Bmi1-GFP+ showed enhanced proliferation of Pax7+SCs pool compared to 
Bmi1-GFP- SCs. This result is consistent with the role of Bmi1 to silence 
P16Ink4a [105]. However, P16Ink4a expression in SCs progenitors can be 
epigenetically controlled also by other PcG. Juan et al (2011) demonstrated that 
Ezh2 controls self-renewal of SCs possibly through silencing P16Ink4a expression 
[102]. It would be interesting to determine whether P16Ink4a is differentially 
expressed in subsets of SCs that are enriched for Bmi1-GFP expression. 
In conclusion, this study emphasizes a novel role of P16Ink4a in Pax7+SCs and 
their progenitors during adult regeneration. Therefore, we believe that P16Ink4a in 
SCs is not only a regulator of cellular senescence promoting aging, but it plays 
an important role in the regulation of SCs progenitors. Future transplant studies 
in injured and mouse models of muscular dystrophy will also address whether 
targeting P16Ink4a may provide a functionally superior SC pool to enhance 
skeletal muscle regeneration. These findings can contribute to develop new 
alternative strategies to enhance SCs function in muscle aging or disease. 
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EXPERIMENTAL PROCEDURES 
 
 
 
ANIMALS 
P16Ink4a knockout mice and mice carrying the P16Ink4a gene flanked by a pair of 
loxP sites (P16flox) were kindly provided by Norman E. Sharpless [115]. Mice 
with two copies of P16flox were crossed with Pax7-CreERtm; P16flox/flox mice [117] 
to generate Pax7-CreERtm+;P16Ink4aflox/flox (Satellite cell-specific P16Ink4a [P16f/f]) 
and Pax7-CreERtm-;P16Ink4aflox/flox control littermate (Ctrl). Bmi1-GFP knock-in 
mice were kindly provided by David T. Scadden [122]. Adult mice are 3-4 
months old and aged mice are 18 months old. Animals were housed and handled 
in accordance with the guidelines of the MGH subcommittee for animal research. 
 
MUSCLE INJURY 
Injury to whole TA/EDL muscle from one leg was made by injection of barium 
chloride (BaCl2) (50 μl, 1.2%) into 30 sites in the lower limb and left to 
regenerate as indicated in results. The other leg remained uninjured as control.  
 
MYOGENIC CELL PREPARATION 
Single fiber cultures 
Single fiber cultures: EDL muscle was digested in 0.2 % Collagenase type I 
(Invitrogen) in DMEM at 37°C and single fibers were gently triturated. Then, 
Single fibers were carefully transferred into 10 ml of 5% Horse Serum (HS) in 
DMEM (Dulbecco’s Modified Eagle Medium, Gibco) and incubated at 37°C in 
5% CO2 for 15 minutes. This was repeated a minimum of three times to remove 
all bad and contracted fibers. Single fibers were then cultured in plating medium, 
PM (10% HS, 0.5% chick embryo extract [CEE; US Biological, Swampscott, 
MA]) in DMEM), for 1 day and then switched to proliferating medium (20% 
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Fetal Bovine Serum [FBS]; Mediatech, Herndon, VA), 10% HS, 2% CEE in 
DMEM)  
Bulk prep for SCs isolation and primary culture 
Hindlimb muscles were incubated in DMEM with 0.2% (w/v) collagenase II 
(Gibco BRL) for 90 minutes at 37°C. Digested muscle was then washed in 
rinsing buffer, RB (Ham’s F-10 nutrient mixture with 10% HS) and dissociated 
into single myofibers by repeated triturating with a Pasteur pipette. 
Myofiber fragments were centrifuged at 1500 rpm for 5 minutes, rinsed and 
incubated in RB, 0.2% collagenase II, 0.4% dispase at 37°C for 30 minutes. To 
release SCs from the fibers, samples were syringed four times, filtered through 
40µm and 20µm filters and spinned at 1500 rpm for 5 minutes. Cell pellet was 
resuspended in Growth Medium (GM) (Ham’s F-10 nutrient mixture with 20% 
FBS, 5 ng/ml basic fibroblast growth factor [R&D Systems, Minneapolis, MN], 
and 1% penicillin/streptomycin [Gibco BRL]) plated in 10 cm dishes coated with 
1/1000 ECM and incubated at 37°C in 5% CO2. SCs progenitors pure culture 
was enriched by pre-plating culture in order to avoid fibroblasts contamination. 
To generate “reserve cell” cultures [139], low passage primary myoblasts were 
maintained in GM and switched to differentiation media DM (3% HS in DMEM) 
for 3 days at high density (80-90% confluency). Cdk4/6 inhibitor IV 
(Calbiochem) was added to culture after adenovirus infection. 
 
FLUORESCENT ACTIVATED CELL SORTING (FACS) 
To obtain highly purified myogenic cells, mononucleated cells were isolated 
from uninjured and regenerating muscle as described [35, 140] with 
modifications. Bulk prepped SCs were incubated in biotinylated anti-vcam1 and 
anti mouse-integrin-α7 for 45 minutes in sorting media (5% FBS, 10% Horse 
Serum in Hams F10), followed by a second incubation with CD31-PE, CD45-PE, 
Streptavidin Alexa647 and anti-mouse Alexa Pacific blue for 30 minutes. Cells 
were washed in sorting media and spun at 1500rpm for 5 minutes, resuspended 
in 500ul sorting media and filtered. Myogenic cells had the following profile: V-
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CAM+, Integrin-α7+,CD31-,CD45-,PI-. Cells were sorted using FACS Aria (BD 
Biosciences). Sorted cells were collected for in vitro analysis or primary culture. 
 
ACTIVATION OF Cre RECOMBINASE 
Low passage myoblasts were infected with adenovirus Ad5CMVCre-eGFP or 
Ad5CMV-eGFP-control (Gene Transfer Vector Core, University of Iowa) 
diluted 1:1000 in GM from a stock titer of 1 x 1010 pfu/ml for 1.5 hr at 37°C. 
Cells were washed with PBS and incubated in fresh PM/GM for 18 hours or 24 
hours and either fixed or replated in GM at equal density for 48 hours and 
switched to fusion media for 3 days. Mice aged 3-4 months were given 
intraperitoneal (i.p.) injection of tamoxifen (TM) (300µl, 10 mg/ml, diluted in 
corn oil [Sigma, St. Louis, MO] daily for 3 days). 
 
HISTOLOGY AND IMMUNOFLUORESCENCE 
Histology and immunofluorescence 
TA muscles were dehydrated in 20% sucrose in PBS (Phosphate Buffered Saline) 
and placed in cryobox with O.C.T. for cryostat sectioning. Muscle section (10µm) 
were fixed in 4% PFA for 10 min at room temperature, permeabilized and 
incubated in blocking solution, BS (10% Goat Serum, PBS/ 0.2% TritoX-100 
[PBST]) for 1 hour. Primary antibodies were incubated in BS overnight at 4°C. 
The day after muscle section were washed with PBST, incubated in BS for 30 
minutes and in secondary antibodies for 1 hour at room temperature, in hydrated 
dark chamber. After several washes with PBST muscle sections were mounted 
and observed at fluorescence microscopy. Immunofluorescence was performed 
on fixed cells and fixed fibers (4% PFA, 10 minutes) after permeabilization 
(0.2% PBT; 10 min) and block (10% GS in PBT). Cells/fibers were incubated in 
primary antibodies overnight at 4°C. Cells/Fibers were washed and blocked in 
10% GS/PBST then incubated in fluorophore-conjugated antibody and DAPI to 
visualize nuclei for 1 hour at room temperature.  
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REAL-TIME RT-PCR 
Total RNA was extracted using TRIZOL® (Invitrogen) from FACS sorted cells 
and myoblasts collected respectively from either uninjured or regenerating 
muscle, or adenovirus infected myoblasts and prepared for qRT-PCR analysis. 
First-strand cDNA was directly synthesized from each cell lysate by the 
SuperScript® II Cells Direct cDNA Synthesis Kit (Invitrogen). Quantitative real-
time PCR was performed with Platinum®SYBR®Green qPCR SuperMix-UDG 
with ROX (Invitrogen). Mouse Cell Cycle RT² Profiler™ PCR Array (Quiagen, 
SABiosciences) was performed on StepOne Plus Real Time System (Applied 
Biosystem) with RT2 SYBR® green ROXTM qPCR Mastermix (Quiagen, 
SABioscience). 
 
WESTERN BLOT 
Primary myoblasts were harvested and lysed in RIPA extraction buffer (50mM 
Tris-HCl, pH 7.4. 1% NP-40, 0.5% sodium deoxycholate, 0.1% sodium dodecyl 
sulfate, 5mM EDTA, 150 mM NaCl and 50mM NaF) supplemented with 
protease and phosphatase inhibitors (complete; Roche). Western Blot were 
probed with antibodies listed in table…Secondary detection was performed with 
HRP-conjugated antibodies. Membrane-bound immune complexes were 
visualized by ECL kit (GE Healthcare, Amersham Biosciences). 
 
SENESCENCE ASSAY 
Cellular senescence assay was performed using Cellular Senescence Assay 
(Millipore) and following manufacturer’s instruction. 
 
STATISTICAL ANALYSIS 
A minimum of 2 and up to 3 replicates was done for all experiments presented. 
Data are presented as means and standard errors of the mean. Comparisons 
between groups were done using a one way analysis of variance. Comparisons 
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within groups were done using a t-test with repeated measures. Differences were 
considered statistically significant at the p < 0.05 level. 
 
ANTIBODIES 
The source and concentration of antibodies: Rat anti-BrdU (1/500, Abcam), 
rabbit anti-ki67 (1/200, Abcam), mouse anti-Pax7 (1/100, DSHB), rabbit anti-
MyoD (1/70 for immunohistochemistry,1/200 for Western Blot, Santa Cruz), 
rabbit anti-Myogenin (1/200, Santa Cruz), mouse anti-BrdU (1/500), rabbit anti-
Myf5 (1/200, Santa Cruz), chick anti-Laminin (1/5000, Abcam), chicken ati-GFP 
(1/500, Invitrogen), rabbit anti-P16 (1/200, Santa Cruz), rabbit anti-cyclin D1 
(1/1000, Cell Signaling), rabbit anti-GAPDH (1:5000,Cell Signaling) mouse 
anti-alpha7integrin (1/200 for FACS, MBL), vcam biotin (1/200 for FACS, 
Novus Bio), CD31-PE and CD45-PE (1/200, BD). The corresponding species-
specific Alexa-conjugated (488, 546, 647) secondary antibodies (Molecular 
Probes) were used at 1/2000 for immunohistochemistry or 1/200 for FACS, anti-
mouse IgG, HRP-linked (1/2000, Cell Signaling), anti-rabbit IgG, HRP-linked 
(1/2000, Cell Signaling). 
 
PRIMERS 
P16 Fw gtgcgatatttgcgttcc, Rev ctctgctcttgggattgg 
P27 Fw aggcaaactctgaggaccggca, Rev tgctccacagtgccagcgttc 
P57 Fw cgaggagcaggacgagaatc, Rev gaagaagtcgttcgcattggc 
P21 Fw tggagtcaggcgcagatccac, Rev cgccatgagcgcatcgcaatc 
Cyclin D1 Fw gcgtaccctgacaccaatctcctc Rev acctcctcttcgcacttctgctcc 
MyoD Fw cactacagtggcgactcagatgc Rev tcgacacagccgcactcttc 
Myogenin Fw ttgctcagctccctcaaccagg Rev tagggtcagccgcgagcaaatg 
Pax7 Fw gtggaatcagaacccgacctc Rev gtagtgggtcctctctcaaaggc 
Myf5 Fw attacagcctgccgggacagag Rev gcaatccaagctggacacggag 
GAPDH Fw aggtcggtgtgaacggatttg, Rev tgtagaccatgtagttgaggtca 
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All reactions for Real time qPCR were performed using the following thermal 
cycler conditions: 50°C for 2 min, 95°C for 2 min followed by 40 cycles of a 3 
step reaction; denaturation at 95°C for 15 sec, annealing at 60°C for 30 sec and 
extension and data collection at 72°C for 30 sec. All genes expression were 
normalized on GAPDH. 
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